<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Burns Trauma</journal-id><journal-id journal-id-type="iso-abbrev">Burns Trauma</journal-id><journal-title-group><journal-title>Burns &#x00026; Trauma</journal-title></journal-title-group><issn pub-type="ppub">2321-3868</issn><issn pub-type="epub">2321-3876</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">30009192</article-id><article-id pub-id-type="pmc">6040609</article-id><article-id pub-id-type="publisher-id">103</article-id><article-id pub-id-type="doi">10.1186/s41038-017-0103-y</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Tissue engineering of skin and regenerative medicine for wound care</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7683-7646</contrib-id><name><surname>Boyce</surname><given-names>Steven T.</given-names></name><address><phone>+1-513-872-6080</phone><email>steven.boyce@uc.edu</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Lalley</surname><given-names>Andrea L.</given-names></name><address><email>alalley@shrinent.org</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2179 9593</institution-id><institution-id institution-id-type="GRID">grid.24827.3b</institution-id><institution>Department of Surgery, </institution><institution>University of Cincinnati, </institution></institution-wrap>P.O. Box 670558, Cincinnati, Ohio 45267-0558 USA </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0449 6752</institution-id><institution-id institution-id-type="GRID">grid.415832.9</institution-id><institution>Research Department, </institution><institution>Shriners Hospitals for Children, </institution></institution-wrap>Cincinnati, Ohio USA </aff></contrib-group><pub-date pub-type="epub"><day>24</day><month>1</month><year>2018</year></pub-date><pub-date pub-type="pmc-release"><day>24</day><month>1</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>6</volume><elocation-id>4</elocation-id><history><date date-type="received"><day>18</day><month>9</month><year>2017</year></date><date date-type="accepted"><day>12</day><month>12</month><year>2017</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2018</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><title>&#x0115f;</title><p id="Par1">Engineering of biologic skin substitutes has progressed over time from individual applications of skin cells, or biopolymer scaffolds, to combinations of cells and scaffolds for treatment, healing, and closure of acute and chronic skin wounds. Skin substitutes may be categorized into three groups: acellular scaffolds, temporary substitutes containing allogeneic skin cells, and permanent substitutes containing autologous skin cells. Combined use of acellular dermal substitutes with permanent skin substitutes containing autologous cells has been shown to provide definitive wound closure in burns involving greater than 90% of the total body surface area. These advances have contributed to reduced morbidity and mortality from both acute and chronic wounds but, to date, have failed to replace all of the structures and functions of the skin. Among the remaining deficiencies in cellular or biologic skin substitutes are hypopigmentation, absence of stable vascular and lymphatic networks, absence of hair follicles, sebaceous and sweat glands, and incomplete innervation. Correction of these deficiencies depends on regulation of biologic pathways of embryonic and fetal development to restore the full anatomy and physiology of uninjured skin. Elucidation and integration of developmental biology into future models of biologic skin substitutes promises to restore complete anatomy and physiology, and further reduce morbidity from skin wounds and scar. This article offers a review of recent advances in skin cell thrapies and discusses the future prospects&#x000a0;in cutaneous regeneration.</p></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Burns</kwd><kwd>Cell therapy</kwd><kwd>Skin&#x000a0;substitute</kwd><kwd>Tissue engineering</kwd><kwd>Wound closure</kwd><kwd>Scar</kwd><kwd>Regenerative medicine</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100011781</institution-id><institution>Shriners Hospitals for Children</institution></institution-wrap></funding-source><award-id>85200</award-id></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000005</institution-id><institution>U.S. Department of Defense</institution></institution-wrap></funding-source><award-id>W81XWH-13-2-0052</award-id></award-group></funding-group><funding-group><award-group><funding-source><institution>National Institutes of Health (US)</institution></funding-source><award-id>1R21AR064341-01A1</award-id></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2018</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p id="Par14">Advances in burn care during the recent past have included improvements in fluid resuscitation, early wound excision, respiratory support and management of inhalation injury, improved nutrition and modulation of the hypermetabolic response, infection control and enhanced immune function, incorporation of aerobic exercise during recovery, and development of anti-scarring strategies [<xref ref-type="bibr" rid="CR1">1</xref>]. These advances have led to significant reductions in mortality, hospital stay, and long-term morbidity. In addition to these comprehensive innovations, skin cell therapies have become part of the treatment plan for extensive burns. This review will summarize several of the most significant advances since 1980 and discuss prospects for further progress in cutaneous regeneration in the future.</p></sec><sec id="Sec2"><title>Review</title><sec id="Sec3"><title>Medical needs</title><p id="Par15">Cutaneous burns can generate a continuum of injuries with increasing depth into the skin. Partial-thickness burns often do not require grafting and, if debrided and treated with antimicrobial dressings, will heal spontaneously from regrowth of epithelial appendages (hair follicles, sebaceous and sweat glands) to cover the wounds. However, deep partial-thickness burns which do not heal within ~&#x02009;3&#x000a0;weeks and full-thickness burns require replacement of the epidermal barrier by transplantation of autologous keratinocytes. Transplantation can be accomplished by either conventional split-thickness skin grafts (STSG), applications of keratinocyte suspensions or sheets, or dermal-epidermal skin substitutes [<xref ref-type="bibr" rid="CR2">2</xref>&#x02013;<xref ref-type="bibr" rid="CR5">5</xref>]. Autologous keratinocytes may persist indefinitely and provide permanent wound closure, whereas allogeneic keratinocytes will remain on the wound for a few days to weeks [<xref ref-type="bibr" rid="CR6">6</xref>&#x02013;<xref ref-type="bibr" rid="CR8">8</xref>], delivering growth factors and extracellular matrix components to wounds that promote more rapid wound closure by autologous cells [<xref ref-type="bibr" rid="CR9">9</xref>]. Combinations of widely meshed and expanded (i.e., 1:6) autografts or micrografts applied to excised, full-thickness burns and covered with allograft [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>] have been reported, but are slow to heal, allow granulation tissue to form, and tend to scar. Conversely, unmeshed sheet grafts applied as early as possible to critical areas (i.e., face, hands, feet, perineum) have been shown to reduce granulation tissue, minimize scar, and produce optimal functional and cosmetic outcomes [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>].</p></sec><sec id="Sec4"><title>Biological requirements and current alternatives</title><p id="Par16">Wound closure after full-thickness burns requires reestablishment of stable epidermis as a minimum requirement. Stability of the epidermis depends on reformation of the basement membrane and vascularized connective tissues to anchor the outer skin to the body. Split-thickness skin satisfies these requirements but does not replace the epidermal adnexa (hair follicles, sebaceous glands, sweat glands) or regenerate a full complement of sensory or motor nerves. Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref> summarizes the anatomic features of uninjured skin compared to STSG, engineered skin substitutes&#x000a0;(ESS), and healed skin after grafting. It is important to note that split-thickness skin at the first harvest does not regenerate hair follicles, sebaceous glands, or sweat glands but does contain pigmented melanocytes and vascular and neural networks which the engineered skin does not. At the second and subsequent harvests of autografts, pigmentation becomes irregular and scar is more pronounced. Compared with autografts, autologous-ESS containing cultured keratinocytes and fibroblasts may also contain &#x0201c;passenger melanocytes&#x0201d; which may colonize the wound and generate focal, but incomplete, pigmentation [<xref ref-type="bibr" rid="CR14">14</xref>&#x02013;<xref ref-type="bibr" rid="CR16">16</xref>]. Of these deficiencies, perhaps the absence of sweat glands is most important to patients with large total body surface area&#x000a0;(TBSA) burns because it impairs the ability to thermo-regulate properly.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Comparisons of cell types in native, engineered and grafted skin (adapted from [<xref ref-type="bibr" rid="CR99">99</xref>])</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Tissue type</th><th>Cell type or structure</th><th>Uninjured skin</th><th>Split-thickness skin graft</th><th>Engineered skin substitutes</th><th>Healed skin after grafting</th></tr></thead><tbody><tr><td rowspan="7">Epidermis</td><td>Keratinocytes</td><td align="center">+</td><td align="center">+</td><td align="center">+</td><td align="center">+</td></tr><tr><td>Hair follicle</td><td align="center">+</td><td align="center">&#x02212;</td><td align="center">&#x02212;</td><td align="center">&#x02212;</td></tr><tr><td>Sebocytes</td><td align="center">+</td><td align="center">&#x02212;</td><td align="center">&#x02212;</td><td align="center">&#x02212;</td></tr><tr><td>Sweat gland</td><td align="center">+</td><td align="center">&#x02212;</td><td align="center">&#x02212;</td><td align="center">&#x02212;</td></tr><tr><td>Melanocytes</td><td align="center">+</td><td align="center">&#x000b1;</td><td align="center">&#x000b1;</td><td align="center">&#x000b1;</td></tr><tr><td>Immune cells</td><td align="center">+</td><td align="center">+</td><td align="center">&#x02212;</td><td align="center">+</td></tr><tr><td>Nerve</td><td align="center">+</td><td align="center">+</td><td align="center">&#x02212;</td><td align="center">&#x000b1;</td></tr><tr><td rowspan="6">Dermis</td><td>Fibroblasts</td><td align="center">+</td><td align="center">+</td><td align="center">&#x000b1;</td><td align="center">+</td></tr><tr><td>Endothelial cells</td><td align="center">+</td><td align="center">+</td><td align="center">&#x02212;</td><td align="center">+</td></tr><tr><td>Extracellular matrix</td><td align="center">+</td><td align="center">&#x000b1;</td><td align="center">&#x000b1;</td><td align="center">&#x000b1;</td></tr><tr><td>Smooth muscle</td><td align="center">+</td><td align="center">+</td><td align="center">&#x02212;</td><td align="center">&#x000b1;</td></tr><tr><td>Immune cells</td><td align="center">+</td><td align="center">+</td><td align="center">&#x02212;</td><td align="center">+</td></tr><tr><td>Nerve</td><td align="center">+</td><td align="center">+</td><td align="center">&#x02212;</td><td align="center">&#x000b1;</td></tr></tbody></table></table-wrap></p><p id="Par17">Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref> provides a partial list of acellular, temporary, and permanent skin substitutes that are either available commercially in the USA or in clinical trials. Acellular skin substitutes recruit fibro-vascular tissues from the wound bed and may consist of either biopolymers, such as collagen and chondroitin-sulfate or elastin (Integra&#x000ae; Dermal Regeneration Template [<xref ref-type="bibr" rid="CR17">17</xref>]; MatriDerm&#x000ae;) [<xref ref-type="bibr" rid="CR18">18</xref>], decellularized human dermis (AlloDerm&#x02122;) [<xref ref-type="bibr" rid="CR19">19</xref>], derivatized hyaluronic acid (Hyalomatrix&#x000ae;) [<xref ref-type="bibr" rid="CR20">20</xref>], or polyurethane (BioTemporizing Matrix, &#x0201c;BTM&#x0201d;) [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR22">22</xref>]. Each of these materials protects open wounds, promotes ingrowth of fibrovascular tissue, and may suppress granulation tissue and scar. However, the biologic materials (i.e., acellular dermis, collagen, hyaluronic acid) are prone to microbial contamination in the absence of antimicrobial agents due to their properties as biological ligands for bacteria and degradation by enzymatic activities [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR24">24</xref>]. In comparison, synthetic polymers (i.e., polyurethane, poly-glycolic/poly-lactic acids) are often degraded by hydrolysis, have fewer microbial binding sites, and are less prone to microbial contamination. If used as dermal substitutes, the acellular materials may require 2 to 4&#x000a0;weeks to vascularize sufficiently to support a STSG. However, if used as a scaffold for cell transplantation, 2&#x000a0;weeks or longer for vascularization would negatively impact cell survival and reduce cellular engraftment and wound closure. Of the available acellular skin substitutes, Integra&#x000ae; currently has the broadest usage for extensive, life-threatening burns and burn scars in the USA [<xref ref-type="bibr" rid="CR25">25</xref>] and has demonstrated very favorable outcomes [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR27">27</xref>] since its introduction in 1996 [<xref ref-type="bibr" rid="CR17">17</xref>]. Similar results have been described recently using the BTM material which currently remains in clinical trial [<xref ref-type="bibr" rid="CR22">22</xref>].<table-wrap id="Tab2"><label>Table 2</label><caption><p>Biologic skin substitutes, commercially available or in clinical trial (adapted from [<xref ref-type="bibr" rid="CR100">100</xref>])</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Model [references]</th><th>Composition</th><th>Indications for use</th></tr></thead><tbody><tr><td align="center" colspan="3">Acellular skin substitutes</td></tr><tr><td>Integra Dermal Regeneration Template [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR101">101</xref>]</td><td>Bovine collagen and chondroitin-sulfate coated with silicone</td><td>Burns, reconstructive surgery</td></tr><tr><td>AlloDerm [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR102">102</xref>]</td><td>Decellularized human dermis</td><td>Repair or replacement of damaged or inadequate integumental tissue</td></tr><tr><td>MatriDerm [<xref ref-type="bibr" rid="CR103">103</xref>, <xref ref-type="bibr" rid="CR104">104</xref>]</td><td>Bovine collagen and elastin</td><td>Burns, reconstructive surgery</td></tr><tr><td>Hyalomatrix [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR105">105</xref>]</td><td>Derivatized hyaluronic acid</td><td>Partial- and full-thickness wounds</td></tr><tr><td>BioTemporizing Matrix [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR106">106</xref>]</td><td>Bilaminate degradable polyurethane</td><td>Burns, reconstructive surgery</td></tr><tr><td align="center" colspan="3">Temporary skin substitutes (dressings)</td></tr><tr><td>Cadaver allograft [<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR107">107</xref>]</td><td>Split-thickness skin from human donors, unfrozen or cryopreserved</td><td>Burns, reconstructive surgery</td></tr><tr><td>Porcine xenograft [<xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR32">32</xref>]</td><td>Split-thickness porcine skin, cryopreserved or lyophilized</td><td>Burns, reconstructive surgery</td></tr><tr><td>Apligraf&#x000ae; [<xref ref-type="bibr" rid="CR108">108</xref>, <xref ref-type="bibr" rid="CR109">109</xref>]</td><td>Allo hF in collagen gel plus stratified allo hK</td><td>Diabetic foot ulcers</td></tr><tr><td>StrataGraft&#x000ae; [<xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR110">110</xref>]</td><td>Allo hF in collagen gel plus stratified allo hK</td><td>Partial-thickness burns</td></tr><tr><td>DermaGraft&#x000ae; [<xref ref-type="bibr" rid="CR111">111</xref>, <xref ref-type="bibr" rid="CR112">112</xref>]</td><td>Allo hF on poly-galactin mesh</td><td>Diabetic foot ulcers</td></tr><tr><td align="center" colspan="3">Permanent skin substitutes (grafts)</td></tr><tr><td>EpiCel&#x000ae; [<xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR113">113</xref>]</td><td>Cultured auto hK multi-layer sheet</td><td>Full-thickness burns</td></tr><tr><td>ReCell&#x000ae; [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR114">114</xref>]</td><td>Uncultured suspension of auto hK, delivered as a spray</td><td>Partial-thickness burns</td></tr><tr><td>Reconstructed skin [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR115">115</xref>]</td><td>Auto hF on acellular scaffold of dermal extracelluar matrix, plus stratified auto hK</td><td>Full-thickness burns, venous and mixed ulcers</td></tr><tr><td>Autologous engineered skin substitute [<xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR116">116</xref>]</td><td>Auto hF on a collagen-GAG scaffold, plus stratified auto hK</td><td>Full-thickness burns</td></tr></tbody></table></table-wrap></p></sec><sec id="Sec5"><title>Cellular skin substitutes</title><p id="Par18">Transplantation of cellular skin substitutes has had wide-ranging results for temporary or permanent wound coverage. Temporary cellular dressings include direct harvest of split-thickness skin, available as either fresh or cryopreserved human cadaver skin [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR29">29</xref>], or porcine skin with storage by chemical fixation or lyophilization [<xref ref-type="bibr" rid="CR30">30</xref>&#x02013;<xref ref-type="bibr" rid="CR32">32</xref>]. In addition, allogeneic human fibroblasts and/or keratinocytes have been combined with degradable scaffolds (i.e., partially denatured collagen (Apligraf&#x02122;; StrataGraft&#x02122;) [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR33">33</xref>], poly-glycolic/poly-lactic acids (DermaGraft&#x02122;)) which deliver growth factors and extracellular matrix to wounds to promote autologous healing but do not persist more than a few days to weeks. Autologous keratinocytes have been applied as cultured cell sheets (EpiCel&#x02122;) [<xref ref-type="bibr" rid="CR34">34</xref>], sprayed cell suspensions prepared during surgery (ReCell&#x02122;) [<xref ref-type="bibr" rid="CR35">35</xref>], with culture-expanded fibroblasts as the dermal component [<xref ref-type="bibr" rid="CR36">36</xref>], or in combination with a polymeric dermal scaffold populated with autologous culture-expanded fibroblasts [<xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR38">38</xref>]. Figure&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref> shows the histologic organization of a dermal-epidermal skin substitute, surgical application, and results in a pediatric patient [<xref ref-type="bibr" rid="CR39">39</xref>]. These approaches have helped to reduce mortality in large burns (&#x0003e;&#x02009;40% TBSA), but they lack hair follicles and glands after transplantation. Limitations of keratinocyte sheets have included poor durability and ulceration [<xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR41">41</xref>] and with sprayed keratinocyte suspensions a requirement for co-application with widely meshed skin autograft [<xref ref-type="bibr" rid="CR42">42</xref>] which reduces the conservation of donor skin and increases scarring after wound closure.<fig id="Fig1"><label>Fig. 1</label><caption><p>Clinical application of autologous engineered skin substitutes (ESS). <bold>a</bold> Histology of ESS shows a collagen-based polymer scaffold populated with cultured dermal fibroblasts and epidermal keratinocytes. Scale bar&#x02009;=&#x02009;0.1&#x000a0;mm. <bold>b</bold> Surgical application of ESS on prepared wounds can be performed using forceps and secured with staples. <bold>c</bold> An African-American subject treated with ESS at 3&#x000a0;years of age shows predominant hypopigmentation. <bold>d</bold> The same subject at 14&#x000a0;years of age has persistent hypopigmentation but has required no reconstruction of the ESS site. Scales in centimeters</p></caption><graphic xlink:href="41038_2017_103_Fig1_HTML" id="MO1"/></fig></p><p id="Par19">Preclinical investigations have reported more complex models that also include melanocytes [<xref ref-type="bibr" rid="CR43">43</xref>&#x02013;<xref ref-type="bibr" rid="CR45">45</xref>], microvascular endothelial cells [<xref ref-type="bibr" rid="CR46">46</xref>&#x02013;<xref ref-type="bibr" rid="CR48">48</xref>], mesenchymal stem cells [<xref ref-type="bibr" rid="CR49">49</xref>&#x02013;<xref ref-type="bibr" rid="CR51">51</xref>], adipocyte stem cells [<xref ref-type="bibr" rid="CR52">52</xref>], sensory nerve cells [<xref ref-type="bibr" rid="CR53">53</xref>], hair follicle progenitor cells [<xref ref-type="bibr" rid="CR54">54</xref>&#x02013;<xref ref-type="bibr" rid="CR56">56</xref>], or induced pluripotent stem cells (iPSCs) [<xref ref-type="bibr" rid="CR57">57</xref>, <xref ref-type="bibr" rid="CR58">58</xref>]. Figure&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref> shows restoration of natural skin color in human ESS with isogeneic melanocytes grafted to immunodeficient mice [<xref ref-type="bibr" rid="CR59">59</xref>] and localization of melanocytes to their normal anatomic location at the basement membrane. These kinds of models promote activation of biological signaling pathways which may stimulate more rapid and complete healing, or drive expression of additional phenotypes to correct anatomic deficiencies. The prospective benefits of progenitor cells may include generation of additional populations of differentiated parenchymal cells (e.g., hair, sweat glands, nerve) in engineered skin grafts. Figure&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref> shows the expression of hair in engineered skin containing neonatal murine skin cells [<xref ref-type="bibr" rid="CR54">54</xref>]. As biologic complexity increases and phenotypes are restored, engineered tissues gain structures and functions that do not result from mechanisms of wound healing. These added properties may derive from embryonic or fetal mechanisms that regulate tissue morphogenesis, in addition to the mechanisms of wound healing. Together, the combination of developmental biology, wound healing, and biomedical engineering constitute the emerging field of regenerative medicine.<fig id="Fig2"><label>Fig. 2</label><caption><p>Correction of pigmentation with cultured autologous melanocytes in preclinical studies. <bold>a</bold> Human engineered skin substitutes (ESS) on immunodeficient mice showing hypopigmentation at 12&#x000a0;weeks after grafting. <bold>b</bold> Correction of hypopigmentation after 12&#x000a0;weeks by addition of isogeneic human melanocytes to ESS. Scales in centimeters. <bold>c</bold> Immunolabeling of epidermis with anti-cytokeratin (red) and the melanocyte-specific maker, tyrosinase-related protein-1 (TRP-1; negative). <bold>d</bold> Immunolabeling of ESS with added melanocytes shows epidermis (red), and TRP-1-positive melanocytes at the dermal-epidermal junction (white arrows) as in uninjured skin. Scale bars&#x02009;=&#x02009;50&#x000a0;&#x003bc;m</p></caption><graphic xlink:href="41038_2017_103_Fig2_HTML" id="MO2"/></fig><fig id="Fig3"><label>Fig. 3</label><caption><p>Induction of hair follicles in vivo from neonatal dermal cells grafted to immunodeficient mice. <bold>a</bold> Human dermal fibroblasts and human epidermal keratinocytes express no hair. <bold>b</bold> Neonatal murine fibroblasts and human neonatal keratinocytes express chimeric hair at 4&#x000a0;weeks after grafting. Scales in cm. <bold>c</bold> Higher magnification showing density of regenerated hair is similar to that on positive control mice. Scale&#x02009;=&#x02009;1&#x000a0;mm</p></caption><graphic xlink:href="41038_2017_103_Fig3_HTML" id="MO3"/></fig></p></sec><sec id="Sec6"><title>Contemporary research and regenerative medicine</title><p id="Par20">Although great progress has been made in reductions of morbidity and mortality in management of burn wounds, some of the most exciting advances remain ahead. These prospective advances include, but are not limited to, (a) complete restoration of skin anatomy and physiology, (b) gene therapies for specific applications, (c) automated and robotic fabrication of engineered tissues to increase efficiencies and reduce costs, and (d) quantification of wounds with non-invasive biophysical instruments.</p><p id="Par21">Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref> summarizes the anatomic and physiologic properties that may be missing from split-thickness skin autograft, ESS, or healed wounds after grafting. Among these phenotypes are epidermal barrier, dermal-epidermal junction, hair folliculogenesis and cycling, sebaceous glands, pigmentation, sensory and motor innervation, cardiovascular systems, and subcutaneous fat. Each of these phenotypes results from specific gene expression pathways that regulate its formation. Examples of these pathways are listed and referenced in the table. It is noteworthy that some of the phenotypes share regulatory pathways, such as hair follicles and sweat glands being regulated by wingless integration site of murine mammary tumor virus (Wnt), &#x003b2;-catenin, ectodysplasin (EDA), and its receptor (EDAR) [<xref ref-type="bibr" rid="CR60">60</xref>, <xref ref-type="bibr" rid="CR61">61</xref>]. Similarly, there are members of the Sry-regulated HMG box (Sox) family of transcription factors that are expressed in formation of hair (Sox-2, -21), sebaceous glands (Sox-9), pigmentation (Sox-10), innervation (Sox-2, -10), and cardiovascular development (Sox-7, -17, -18). Despite these similarities, each pathway is expressed in a context of its microenvironment (e.g., stem cells, extracellular matrix) which also contributes to the genesis and stability of the phenotype. Undoubtedly, as continuing studies in developmental biology elucidate these pathways, greater capabilities to guide the anatomy and physiology of biologic skin substitutes will be gained.<table-wrap id="Tab3"><label>Table 3</label><caption><p>Developmental pathways and regulatory factors for cutaneous phenotypes (adapted from [<xref ref-type="bibr" rid="CR100">100</xref>])</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Cutaneous structures and phenotypes</th><th>Regulatory pathways and factors</th></tr></thead><tbody><tr><td>Epidermal barrier</td><td>Ca<sup>2+</sup> [<xref ref-type="bibr" rid="CR117">117</xref>, <xref ref-type="bibr" rid="CR118">118</xref>]<break/>Transglutaminase, loricrin [<xref ref-type="bibr" rid="CR119">119</xref>, <xref ref-type="bibr" rid="CR120">120</xref>]<break/>Essential fatty acids, stratum corneum lipids [<xref ref-type="bibr" rid="CR121">121</xref>, <xref ref-type="bibr" rid="CR122">122</xref>]</td></tr><tr><td>Dermal-epidermal junction</td><td>Integrins [<xref ref-type="bibr" rid="CR123">123</xref>, <xref ref-type="bibr" rid="CR124">124</xref>]<break/>FAK-Ras-MapK [<xref ref-type="bibr" rid="CR60">60</xref>, <xref ref-type="bibr" rid="CR124">124</xref>]<break/>PKB/Akt-ERK1/2 [<xref ref-type="bibr" rid="CR125">125</xref>]</td></tr><tr><td>Hair follicle genesis and cycling</td><td>Wnt/&#x003b2;-catenin/DKK4/BMPs [<xref ref-type="bibr" rid="CR60">60</xref>, <xref ref-type="bibr" rid="CR61">61</xref>]<break/>EDA/EDAR [<xref ref-type="bibr" rid="CR126">126</xref>, <xref ref-type="bibr" rid="CR127">127</xref>]<break/>Sox-2, -21 [<xref ref-type="bibr" rid="CR128">128</xref>, <xref ref-type="bibr" rid="CR129">129</xref>]</td></tr><tr><td>Sebaceous glands</td><td>Rac1-Sox9-Lrig1 [<xref ref-type="bibr" rid="CR61">61</xref>, <xref ref-type="bibr" rid="CR130">130</xref>]<break/>Wnt; Blimp1; IHH; c-myc [<xref ref-type="bibr" rid="CR131">131</xref>]<break/>TGF&#x003b2;-1 [<xref ref-type="bibr" rid="CR132">132</xref>]</td></tr><tr><td>Sweat glands</td><td>Wnt/&#x003b2;-catenin [<xref ref-type="bibr" rid="CR133">133</xref>]<break/>EDA/EDAR/NF-&#x003ba;B [<xref ref-type="bibr" rid="CR134">134</xref>]<break/>DKK4, SHH [<xref ref-type="bibr" rid="CR135">135</xref>]</td></tr><tr><td>Pigmentation</td><td>c-kit/SCF; [<xref ref-type="bibr" rid="CR136">136</xref>]<break/>ET-3/EDNRB2 [<xref ref-type="bibr" rid="CR137">137</xref>]<break/>Sox-10/Mitf; Eph/EphR; [<xref ref-type="bibr" rid="CR138">138</xref>]</td></tr><tr><td>Sensory and motor innervation</td><td>c-jun [<xref ref-type="bibr" rid="CR139">139</xref>]<break/>Sox-2,-10 [<xref ref-type="bibr" rid="CR55">55</xref>]<break/>Oct-6; Krox-20; Pax 3 [<xref ref-type="bibr" rid="CR140">140</xref>]</td></tr><tr><td>Cardiovascular system</td><td>Sox-7, -17, -18 [<xref ref-type="bibr" rid="CR141">141</xref>]<break/>Mef2c/&#x003b2;-catenin [<xref ref-type="bibr" rid="CR142">142</xref>]<break/>VEGF; HOXA9, VEZF1 [<xref ref-type="bibr" rid="CR143">143</xref>]</td></tr><tr><td>Subcutaneous fat</td><td>PPAR&#x003b3; [<xref ref-type="bibr" rid="CR144">144</xref>]<break/>Pref-1; Fabp4 [<xref ref-type="bibr" rid="CR145">145</xref>]<break/>Myf5; Ebf2; Prdm16; Pgc-1&#x003b1; [<xref ref-type="bibr" rid="CR146">146</xref>]</td></tr></tbody></table><table-wrap-foot><p><italic>EDA</italic>&#x000a0;ectodysplasin, <italic>EDAR</italic> ectodysplasin&#x000a0;receptor, <italic>TGF&#x003b2;-1</italic>&#x000a0;transforming growth factor&#x000a0;&#x003b2;-1, <italic>VEGF</italic>, vascular endothelial growth factor</p></table-wrap-foot></table-wrap></p><p id="Par22">Gene therapies for the skin have been studied extensively over the years and have met with limited success [<xref ref-type="bibr" rid="CR62">62</xref>&#x02013;<xref ref-type="bibr" rid="CR64">64</xref>]. Risks from use of retrovirus-based expression systems suggest that lentiviral-mediated genetic modifications may have greater safety and efficacy in prospective studies [<xref ref-type="bibr" rid="CR65">65</xref>, <xref ref-type="bibr" rid="CR66">66</xref>]. However, at least two examples of gene therapy in skin substitutes are currently active in the areas of innate antimicrobial peptides (e.g., cathelicidins, &#x003b2;-defensins) [<xref ref-type="bibr" rid="CR67">67</xref>, <xref ref-type="bibr" rid="CR68">68</xref>] in allogeneic engineered skin to promote healing of chronic wounds and collagen VII for recessive dystrophic epidermolysis bullosa (RDEB) [<xref ref-type="bibr" rid="CR69">69</xref>, <xref ref-type="bibr" rid="CR70">70</xref>]. These approaches to gene therapies require careful considerations for safety and efficacy in clinical applications. Constitutive overexpression of human beta defensin-3 with a non-viral plasmid DNA in an allogeneic model of a skin substitute has been evaluated for microbial management of contaminated wounds and was not tumorigenic [<xref ref-type="bibr" rid="CR71">71</xref>]. These kinds of approaches provide novel examples for wound management and correction of congenital skin diseases and open countless opportunities for future reductions of morbidity and mortality from skin wounds. The CRISPR/Cas9 system for gene editing [<xref ref-type="bibr" rid="CR72">72</xref>] offers an alternative for genetic modification of cells without the associated risks of viral vectors [<xref ref-type="bibr" rid="CR73">73</xref>, <xref ref-type="bibr" rid="CR74">74</xref>].</p><p id="Par23">In addition to unique compositions of cells, gene expression, and scaffolds to construct analogs of skin, a critical and limiting factor to greater availability of skin substitutes is manual fabrication of these complex materials. To address this limitation, numerous methods for robotic fabrication of skin and other tissue substitutes have been described [<xref ref-type="bibr" rid="CR75">75</xref>]. Many of these approaches are highly precise and involve extrusion of cell-populated matrices into specific shapes for transplantation. For skin models, techniques include multi-layering of multiple cell types [<xref ref-type="bibr" rid="CR76">76</xref>], &#x0201c;ink-jet printing&#x0201d; [<xref ref-type="bibr" rid="CR77">77</xref>], or transfer of cell-matrix droplets onto a culture substrate by actuation of a laser pulse [<xref ref-type="bibr" rid="CR78">78</xref>]. Although these robotic systems accomplish physical transfers with relatively high efficiency, they may injure cells by transient exposures to high pressure, temperature, or chemical toxicities. Importantly, cells suspended in viscous scaffolds may be deprived of cellular attachments to cell surface receptors (e.g., integrins, cadherins), resulting in irreversible proliferative arrest and apoptosis [<xref ref-type="bibr" rid="CR79">79</xref>]. Avoidance of these kinds of growth inhibitions will be essential to the eventual success of robotic systems. It is important to recognize that these kinds of attachment and signaling deprivations do not occur during fetal morphogenesis or wound healing. Therefore, providing tissue-specific ligands for cell surface receptors, or maintaining signaling pathways that regulate proliferation, will likely be required to optimize the mitotic rates of cells in engineered tissues. One approach to satisfying this requirement is formation of cellular organoids [<xref ref-type="bibr" rid="CR75">75</xref>] which provide cell-cell attachments to preserve cell cycle signaling without attachment of cells to scaffolds or plastic vessels.</p><p id="Par24">Assessments of skin wounds have progressed from subjective examinations by clinicians to more objective measures with non-invasive instruments for both diagnostic and prognostic evaluations. For diagnostic purposes, scanning laser Doppler flowmetry has been shown to provide accurate assessments of burn depth and color with simultaneous image capture [<xref ref-type="bibr" rid="CR80">80</xref>&#x02013;<xref ref-type="bibr" rid="CR82">82</xref>]. Accuracy in determining the TBSA of burns has also been improved with computer software for digital mapping of skin injuries to better calculate critical interventions such as fluid resuscitation. Three-dimensional photography and laser surface scanning [<xref ref-type="bibr" rid="CR83">83</xref>, <xref ref-type="bibr" rid="CR84">84</xref>] provide topographic data that may be coupled with body mapping to generate virtual representations of patients that can be revised during the hospital course to construct a timeline of clinical progress. Non-invasive instruments for assessments of color, shape, surface texture, visco-elastic properties, blood flow, temperature, pH, surface hydration, and water vapor transmission have been adapted from applications in dermatology for more objective determinations of scars [<xref ref-type="bibr" rid="CR85">85</xref>]. Although these kinds of instruments have high accuracy, they often provide assessments of individual points within fields of wounds or scars which must be considered in sampling plans for data interpretation. Because point measures typically do not represent heterogeneous wounds, data collection at multiple sites is needed to compensate for the subjective selection of individual points to measure within the treatment field. With these kinds of considerations, application of non-invasive instruments for wound assessments has been shown to correct for inter-rater variability in ordinal or observational evaluations of wounds and scars.</p></sec><sec id="Sec7"><title>Regulatory environments and requirements</title><p id="Par25">Safety and efficacy of skin substitutes are regulated in the USA by the US Food and Drug Administration (FDA). Biologic skin substitutes have increased in complexity from models that replace either dermis or epidermis, to dermal-epidermal models, to those that deliver combinations of biopolymer scaffolds, multiple cell types, or multiple cell sources, to those that express gene products for prospective improvements in wound healing. This spectrum of unprecedented materials presented questions regarding the regulatory framework within which each model would be evaluated for consideration of permission to market. Traditionally, the FDA has consisted of three centers for evaluation of human therapeutics: the Center for Devices and Radiologic Health (CDRH), the Center for Biologics Evaluation and Research (CBER), and the Center for Drug Evaluation and Research (CDER). Availability of cadaveric allograft has been provided under regulations for tissue banking, which are administered by CBER. As the spectrum of research models of skin substitutes broadened during the 1980s and 1990s, several investigative therapies had components that required consideration by multiple centers at FDA. The agency responded proactively with two initiatives that have contributed to greater clarity of the regulatory process and with Guidance for Industry [<xref ref-type="bibr" rid="CR86">86</xref>, <xref ref-type="bibr" rid="CR87">87</xref>] on how to propose a path to market.</p><p id="Par26">An early initiative was FDA&#x02019;s participation in establishment of definitions and standards for tissue-engineered medical products (TEMPs) through formation of a Division IV of Committee F04 for medical devices through the American Society for Testing and Materials (ASTM) [<xref ref-type="bibr" rid="CR88">88</xref>]. Beginning in 1997, this organization has had members from academics, government, and industry participating in a consensus process for composing definitions of materials and provision of methods for calibration and testing of the materials. With regard to skin substitutes, the ASTM process has resulted in a Standard Guide for Classification of Therapeutic Skin Substitutes [<xref ref-type="bibr" rid="CR89">89</xref>], providing consensus definitions and nomenclature. The second initiative was FDA&#x02019;s establishment in 2002 of the Office of Combination Products, by which investigative therapies are reviewed initially for their primary mode of action [<xref ref-type="bibr" rid="CR90">90</xref>]. This office confers with the Centers for Human Therapeutics to designate new therapies at a lead center at FDA with participation from other centers as appropriate. Together, these initiatives have added clarity to the assignment of novel therapeutics to a designated regulatory path [<xref ref-type="bibr" rid="CR91">91</xref>]. In addition to providing a framework for innovative investigative therapies, FDA provides &#x0201c;expanded access&#x0201d; or &#x0201c;compassionate use&#x0201d; permissions for treatment of selected conditions that present high risks of mortality or morbidity to patients [<xref ref-type="bibr" rid="CR92">92</xref>, <xref ref-type="bibr" rid="CR93">93</xref>].</p><p id="Par27">More recently, the 21st Century Cures Act (Cures Act) was signed into law in the USA in December, 2016. As the name implies, this law is intended to facilitate and expedite the availability of novel therapies to patients with serious, or potentially life-threatening, conditions. The Cures Act provides for expedited therapeutic development programs including the Regenerative Medicine Advanced Therapy (RMAT) designation for eligible biologics products, and the Breakthrough Devices program which is designed to facilitate the review of certain innovative medical devices [<xref ref-type="bibr" rid="CR94">94</xref>]. These new designations by FDA are in addition to previous expedited regulatory pathways of Fast Track development [<xref ref-type="bibr" rid="CR95">95</xref>], Breakthrough Therapy designation [<xref ref-type="bibr" rid="CR96">96</xref>], Accelerated Approval [<xref ref-type="bibr" rid="CR97">97</xref>], and Priority Review designation for drugs [<xref ref-type="bibr" rid="CR98">98</xref>]. Together, these alternative pathways to provisional or full marketing are likely to increase access to the most advanced therapies by patient populations with the greatest medical needs.</p></sec></sec><sec id="Sec8"><title>Conclusions</title><p id="Par28">Future prospects for biologic skin substitutes are extensive and diverse. Advances in use and regulation of stem cells in the skin are highly likely to lead to autologous skin substitutes with greater homology to uninjured skin by providing restoration of skin pigmentation, epidermal appendages (hair, sebaceous and sweat glands), a vascular plexus, and subcutaneous tissues. Genetic modification of autologous cells opens tremendous opportunities for regulation of wound closure, reductions in scar formation, and correction of congenital diseases. As these advances in biologic skin substitutes translate into clinical care, it can be predicted with confidence that reductions in morbidity from acquired and congenital skin diseases will also be realized.</p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>ASTM</term><def><p id="Par2">American Society for Testing and Materials</p></def></def-item><def-item><term>BTM</term><def><p id="Par3">BioTemporizing Matrix</p></def></def-item><def-item><term>CBER</term><def><p id="Par4">Center for Biologics Evaluation and Research</p></def></def-item><def-item><term>CDER</term><def><p id="Par5">Center for Drug Evaluation and Research</p></def></def-item><def-item><term>CDRH</term><def><p id="Par6">Center for Devices and Radiologic Health</p></def></def-item><def-item><term>CRISPR</term><def><p id="Par7">Clustered Regularly Interspaced Short Palindromic Repeats</p></def></def-item><def-item><term>Cures Act</term><def><p id="Par8">The 21st Century Cures Act</p></def></def-item><def-item><term>FDA</term><def><p id="Par9">Food and Drug Administration</p></def></def-item><def-item><term>RMAT</term><def><p id="Par10">Regenerative Medicine Advanced Therapy</p></def></def-item><def-item><term>STSG</term><def><p id="Par11">Split-thickness skin graft</p></def></def-item><def-item><term>TEMPs</term><def><p id="Par12">Tissue-engineered medical products</p></def></def-item><def-item><term>RDEB</term><def><p id="Par13">recessive dystrophic epidermolysis bullosa</p></def></def-item></def-list></glossary><ack><title>Acknowledgements</title><p>The authors gratefully acknowledge the expert technical assistance of Christopher Lloyd and Mark Kleiner for the performance of the preclinical studies, Mary Rolfes for the histology, Laura James for the statistical support, and Laura Fowler, RN, and Judy Nelson, RN, for the performance of the clinical research studies.</p><sec id="FPar1"><title>Funding</title><p id="Par29">Funding of the authors&#x02019; studies has been provided by the National Institutes of Health (grant no. 1R21AR064341-01A1), the US Department of Defense (contract no. W81XWH-13-2-0052), and the Shriners Hospitals for Children (grant nos. 85200 and 84050).</p></sec><sec id="FPar2"><title>Availability of data and materials</title><p id="Par30">Data and materials in this manuscript are referenced from previous publications and may be available from commercial suppliers or upon request from the reference laboratories.</p></sec></ack><notes notes-type="author-contribution"><title>Authors&#x02019; contributions</title><p>Both authors contributed to the content of this manuscript and provided consent for publication. Both authors read and approved the final manuscript.</p></notes><notes notes-type="COI-statement"><sec id="FPar3"><title>Ethics approval and consent to participate</title><p id="Par31">All human subject research was performed with approval of the University of Cincinnati Institutional Review Board with regulatory oversight by the US Food and Drug Administration. All animal subject research was performed with approval of the University of Cincinnati Institutional Animal Care and Use Committee and the Animal Care and Use Research Office of the US Army Medical Research and Materiel Command.</p></sec><sec id="FPar4"><title>Consent for publication</title><p id="Par32">An informed consent to publish de-identified data was obtained from the subjects.</p></sec><sec id="FPar5"><title>Competing interests</title><p id="Par33">The authors declare that they have no competing interests.</p></sec></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finnerty</surname><given-names>CC</given-names></name><name><surname>Capek</surname><given-names>K</given-names></name><name><surname>Voigt</surname><given-names>C</given-names></name><name><surname>Hundeshagen</surname><given-names>G</given-names></name><name><surname>Cambiaso-Daniel</surname><given-names>J</given-names></name><name><surname>Porter</surname><given-names>C</given-names></name><name><surname>Sousse</surname><given-names>LE</given-names></name><name><surname>El Ayadi</surname><given-names>A</given-names></name><name><surname>Zapata-Sirvent</surname><given-names>R</given-names></name><name><surname>Guillory</surname><given-names>A</given-names></name><etal/></person-group><article-title>The P50 research center in perioperative sciences: how the investment by the National Institute of General Medical Sciences in Team Science has reduced post-burn mortality</article-title><source>J Trauma Acute Care Surg</source><year>2017</year><volume>83</volume><issue>3</issue><fpage>532</fpage><lpage>542</lpage><pub-id pub-id-type="doi">10.1097/TA.0000000000001644</pub-id><pub-id pub-id-type="pmid">28697015</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warden</surname><given-names>GD</given-names></name><name><surname>Saffle</surname><given-names>JR</given-names></name><name><surname>Kravitz</surname><given-names>M</given-names></name></person-group><article-title>A two-stage technique for excision and grafting of burn wounds</article-title><source>J Trauma</source><year>1982</year><volume>22</volume><issue>2</issue><fpage>98</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1097/00005373-198202000-00004</pub-id><pub-id pub-id-type="pmid">7038136</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wood</surname><given-names>FM</given-names></name><name><surname>Giles</surname><given-names>N</given-names></name><name><surname>Stevenson</surname><given-names>A</given-names></name><name><surname>Rea</surname><given-names>S</given-names></name><name><surname>Fear</surname><given-names>M</given-names></name></person-group><article-title>Characterisation of the cell suspension harvested from the dermal epidermal junction using a ReCell(R) kit</article-title><source>Burns</source><year>2012</year><volume>38</volume><issue>1</issue><fpage>44</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1016/j.burns.2011.03.001</pub-id><pub-id pub-id-type="pmid">22079538</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Green</surname><given-names>H</given-names></name><name><surname>Kehinde</surname><given-names>O</given-names></name><name><surname>Thomas</surname><given-names>J</given-names></name></person-group><article-title>Growth of human epidermal cells into multiple epithelia suitable for grafting</article-title><source>Proc Natl Acad Sci U S A</source><year>1979</year><volume>76</volume><fpage>5665</fpage><lpage>5668</lpage><pub-id pub-id-type="doi">10.1073/pnas.76.11.5665</pub-id><pub-id pub-id-type="pmid">293669</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyce</surname><given-names>ST</given-names></name><name><surname>Hansbrough</surname><given-names>JF</given-names></name></person-group><article-title>Biologic attachment, growth, and differentiation of cultured human epidermal keratinocytes on a graftable collagen and chondroitin-6-sulfate substrate</article-title><source>Surgery</source><year>1988</year><volume>103</volume><fpage>421</fpage><lpage>431</lpage><pub-id pub-id-type="pmid">2451303</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Falanga</surname><given-names>V</given-names></name><name><surname>Sabolinski</surname><given-names>M</given-names></name></person-group><article-title>A bilayered living skin construct (APLIGRAF) accelerates complete closure of hard-to-heal venous ulcers</article-title><source>Wound Repair Regen</source><year>1999</year><volume>7</volume><issue>4</issue><fpage>201</fpage><lpage>207</lpage><pub-id pub-id-type="doi">10.1046/j.1524-475X.1999.00201.x</pub-id><pub-id pub-id-type="pmid">10781211</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Griffiths</surname><given-names>M</given-names></name><name><surname>Ojeh</surname><given-names>N</given-names></name><name><surname>Livingstone</surname><given-names>R</given-names></name><name><surname>Price</surname><given-names>R</given-names></name><name><surname>Navsaria</surname><given-names>H</given-names></name></person-group><article-title>Survival of Apligraf in acute human wounds</article-title><source>Tissue Eng</source><year>2004</year><volume>10</volume><issue>7-8</issue><fpage>1180</fpage><lpage>1195</lpage><pub-id pub-id-type="doi">10.1089/ten.2004.10.1180</pub-id><pub-id pub-id-type="pmid">15363174</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Centanni</surname><given-names>JM</given-names></name><name><surname>Straseski</surname><given-names>JA</given-names></name><name><surname>Wicks</surname><given-names>A</given-names></name><name><surname>Hank</surname><given-names>JA</given-names></name><name><surname>Rasmussen</surname><given-names>CA</given-names></name><name><surname>Lokuta</surname><given-names>MA</given-names></name><name><surname>Schurr</surname><given-names>MJ</given-names></name><name><surname>Foster</surname><given-names>KN</given-names></name><name><surname>Faucher</surname><given-names>LD</given-names></name><name><surname>Caruso</surname><given-names>DM</given-names></name><etal/></person-group><article-title>StrataGraft skin substitute is well-tolerated and is not acutely immunogenic in patients with traumatic wounds: results from a prospective, randomized, controlled dose escalation trial</article-title><source>Ann Surg</source><year>2011</year><volume>253</volume><issue>4</issue><fpage>672</fpage><lpage>683</lpage><pub-id pub-id-type="doi">10.1097/SLA.0b013e318210f3bd</pub-id><pub-id pub-id-type="pmid">21475006</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parenteau</surname><given-names>NL</given-names></name><name><surname>Sabolinski</surname><given-names>M</given-names></name><name><surname>Prosky</surname><given-names>S</given-names></name><name><surname>Nolte</surname><given-names>C</given-names></name><name><surname>Oleson</surname><given-names>M</given-names></name><name><surname>Kriwet</surname><given-names>K</given-names></name><name><surname>Bilbo</surname><given-names>P</given-names></name></person-group><article-title>Biological and physical factors influencing the successful engraftment of a cultured human skin substitute</article-title><source>Biotechnol Bioeng</source><year>1996</year><volume>523</volume><fpage>3</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1097-0290(19961005)52:1&#x0003c;3::AID-BIT1&#x0003e;3.0.CO;2-P</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alexander</surname><given-names>JW</given-names></name><name><surname>MacMillan</surname><given-names>BG</given-names></name><name><surname>Law</surname><given-names>E</given-names></name><name><surname>Kittur</surname><given-names>DS</given-names></name></person-group><article-title>Treatment of severe burns with widely meshed skin autograft, and meshed skin allograft overlay</article-title><source>J Trauma</source><year>1981</year><volume>21</volume><issue>6</issue><fpage>433</fpage><lpage>438</lpage><pub-id pub-id-type="pmid">7230295</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Medina</surname><given-names>A</given-names></name><name><surname>Riegel</surname><given-names>T</given-names></name><name><surname>Nystad</surname><given-names>D</given-names></name><name><surname>Tredget</surname><given-names>EE</given-names></name></person-group><article-title>Modified meek micrografting technique for wound coverage in extensive burn injuries</article-title><source>J Burn Care Res</source><year>2016</year><volume>37</volume><issue>5</issue><fpage>305</fpage><lpage>313</lpage><pub-id pub-id-type="doi">10.1097/BCR.0000000000000244</pub-id><pub-id pub-id-type="pmid">27355651</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gallico Iii</surname><given-names>GG</given-names></name><name><surname>O'Connor</surname><given-names>NE</given-names></name><name><surname>Compton</surname><given-names>CC</given-names></name><name><surname>Remensynder</surname><given-names>JP</given-names></name><name><surname>Kehinde</surname><given-names>O</given-names></name><name><surname>Green</surname><given-names>H</given-names></name></person-group><article-title>Cultured epithelial autografts for giant congenital nevi</article-title><source>Plast Reconstr Surg</source><year>1989</year><volume>84</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1097/00006534-198907000-00001</pub-id><pub-id pub-id-type="pmid">2660171</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nikkhah</surname><given-names>D</given-names></name><name><surname>Booth</surname><given-names>S</given-names></name><name><surname>Tay</surname><given-names>S</given-names></name><name><surname>Gilbert</surname><given-names>P</given-names></name><name><surname>Dheansa</surname><given-names>B</given-names></name></person-group><article-title>Comparing outcomes of sheet grafting with 1:1 mesh grafting in patients with thermal burns: a randomized trial</article-title><source>Burns</source><year>2015</year><volume>41</volume><issue>2</issue><fpage>257</fpage><lpage>264</lpage><pub-id pub-id-type="doi">10.1016/j.burns.2014.07.023</pub-id><pub-id pub-id-type="pmid">25175303</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Compton</surname><given-names>CC</given-names></name><name><surname>Warland</surname><given-names>G</given-names></name><name><surname>Kratz</surname><given-names>G</given-names></name></person-group><article-title>Melanocytes in cultured epithelial grafts are depleted with serial subcultivation and cryopreservation: implications for clinical outcome</article-title><source>J Burn Care Rehabil</source><year>1998</year><volume>19</volume><issue>4</issue><fpage>330</fpage><lpage>336</lpage><pub-id pub-id-type="doi">10.1097/00004630-199807000-00011</pub-id><pub-id pub-id-type="pmid">9710732</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harriger</surname><given-names>MD</given-names></name><name><surname>Warden</surname><given-names>GD</given-names></name><name><surname>Greenhalgh</surname><given-names>DG</given-names></name><name><surname>Kagan</surname><given-names>RJ</given-names></name><name><surname>Boyce</surname><given-names>ST</given-names></name></person-group><article-title>Pigmentation and microanatomy of skin regenerated from composite grafts of cultured cells and biopolymers applied to full-thickness burn wounds</article-title><source>Transplantation</source><year>1995</year><volume>59</volume><issue>5</issue><fpage>702</fpage><lpage>707</lpage><pub-id pub-id-type="doi">10.1097/00007890-199503150-00011</pub-id><pub-id pub-id-type="pmid">7886796</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greenhalgh</surname><given-names>DG</given-names></name></person-group><article-title>A primer on pigmentation</article-title><source>J Burn Care Res</source><year>2015</year><volume>36</volume><issue>2</issue><fpage>247</fpage><lpage>257</lpage><pub-id pub-id-type="doi">10.1097/BCR.0000000000000224</pub-id><pub-id pub-id-type="pmid">25501768</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><mixed-citation publication-type="other">Heimbach D, Luterman A, Burke J, Cram A, Herndon D, Hunt J, Jordan M, McManus W, Solem L, Warden G, Zawacki B. Artificial dermis for major burns: a multi-center randomized clinical trial. Ann Surg. 1988;208(3):313&#x02013;9.</mixed-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atherton</surname><given-names>DD</given-names></name><name><surname>Tang</surname><given-names>R</given-names></name><name><surname>Jones</surname><given-names>I</given-names></name><name><surname>Jawad</surname><given-names>M</given-names></name></person-group><article-title>Early excision and application of matriderm with simultaneous autologous skin grafting in facial burns</article-title><source>Plast Reconstr Surg</source><year>2010</year><volume>125</volume><issue>2</issue><fpage>60e</fpage><lpage>61e</lpage><pub-id pub-id-type="doi">10.1097/PRS.0b013e3181c725e5</pub-id><pub-id pub-id-type="pmid">20124807</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jansen</surname><given-names>LA</given-names></name><name><surname>De</surname><given-names>CP</given-names></name><name><surname>Guay</surname><given-names>NA</given-names></name><name><surname>Lineaweaver</surname><given-names>WC</given-names></name><name><surname>Shokrollahi</surname><given-names>K</given-names></name></person-group><article-title>The evidence base for the acellular dermal matrix AlloDerm: a systematic review</article-title><source>Ann Plast Surg</source><year>2013</year><volume>70</volume><issue>5</issue><fpage>587</fpage><lpage>594</lpage><pub-id pub-id-type="doi">10.1097/SAP.0b013e31827a2d23</pub-id><pub-id pub-id-type="pmid">23542841</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gravante</surname><given-names>G</given-names></name><name><surname>Delogu</surname><given-names>D</given-names></name><name><surname>Giordan</surname><given-names>N</given-names></name><name><surname>Morano</surname><given-names>G</given-names></name><name><surname>Montone</surname><given-names>A</given-names></name><name><surname>Esposito</surname><given-names>G</given-names></name></person-group><article-title>The use of Hyalomatrix PA in the treatment of deep partial-thickness burns</article-title><source>J Burn Care Res</source><year>2007</year><volume>28</volume><issue>2</issue><fpage>269</fpage><lpage>274</lpage><pub-id pub-id-type="doi">10.1097/BCR.0B013E318031A236</pub-id><pub-id pub-id-type="pmid">17351444</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greenwood</surname><given-names>JE</given-names></name><name><surname>Dearman</surname><given-names>BL</given-names></name></person-group><article-title>Split skin graft application over an integrating, biodegradable temporizing polymer matrix: immediate and delayed</article-title><source>J Burn Care Res</source><year>2012</year><volume>33</volume><issue>1</issue><fpage>7</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1097/BCR.0b013e3182372be9</pub-id><pub-id pub-id-type="pmid">22079917</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greenwood</surname><given-names>JE</given-names></name><name><surname>Wagstaff</surname><given-names>MJ</given-names></name><name><surname>Rooke</surname><given-names>M</given-names></name><name><surname>Caplash</surname><given-names>Y</given-names></name></person-group><article-title>Reconstruction of extensive calvarial exposure after major burn injury in 2 stages using a biodegradable polyurethane matrix</article-title><source>Eplasty</source><year>2016</year><volume>16</volume><fpage>e17</fpage><pub-id pub-id-type="pmid">27222681</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muangman</surname><given-names>P</given-names></name><name><surname>Deubner</surname><given-names>H</given-names></name><name><surname>Honari</surname><given-names>S</given-names></name><name><surname>Heimbach</surname><given-names>DM</given-names></name><name><surname>Engrav</surname><given-names>LH</given-names></name><name><surname>Klein</surname><given-names>MB</given-names></name><name><surname>Gibran</surname><given-names>NS</given-names></name></person-group><article-title>Correlation of clinical outcome of integra application with microbiologic and pathological biopsies</article-title><source>J Trauma</source><year>2006</year><volume>61</volume><issue>5</issue><fpage>1212</fpage><lpage>1217</lpage><pub-id pub-id-type="doi">10.1097/01.ta.0000195982.71400.84</pub-id><pub-id pub-id-type="pmid">17099531</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heimbach</surname><given-names>DM</given-names></name><name><surname>Warden</surname><given-names>GD</given-names></name><name><surname>Luterman</surname><given-names>A</given-names></name><name><surname>Jordan</surname><given-names>MH</given-names></name><name><surname>Ozobia</surname><given-names>N</given-names></name><name><surname>Ryan</surname><given-names>CM</given-names></name><name><surname>Voigt</surname><given-names>DW</given-names></name><name><surname>Hickerson</surname><given-names>WL</given-names></name><name><surname>Saffle</surname><given-names>JR</given-names></name><name><surname>DeClement</surname><given-names>FA</given-names></name><etal/></person-group><article-title>Multicenter postapproval clinical trial of Integra dermal regeneration template for burn treatment</article-title><source>J Burn Care Rehabil</source><year>2003</year><volume>24</volume><issue>1</issue><fpage>42</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1097/00004630-200301000-00009</pub-id><pub-id pub-id-type="pmid">12543990</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Branski</surname><given-names>LK</given-names></name><name><surname>Herndon</surname><given-names>DN</given-names></name><name><surname>Pereira</surname><given-names>C</given-names></name><name><surname>Mlcak</surname><given-names>RP</given-names></name><name><surname>Celis</surname><given-names>MM</given-names></name><name><surname>Lee</surname><given-names>JO</given-names></name><name><surname>Sanford</surname><given-names>AP</given-names></name><name><surname>Norbury</surname><given-names>WB</given-names></name><name><surname>Zhang</surname><given-names>XJ</given-names></name><name><surname>Jeschke</surname><given-names>MG</given-names></name></person-group><article-title>Longitudinal assessment of Integra in primary burn management: a randomized pediatric clinical trial</article-title><source>Crit Care Med</source><year>2007</year><volume>35</volume><issue>11</issue><fpage>2615</fpage><lpage>2623</lpage><pub-id pub-id-type="doi">10.1097/01.CCM.0000285991.36698.E2</pub-id><pub-id pub-id-type="pmid">17828040</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kopp</surname><given-names>J</given-names></name><name><surname>Magnus</surname><given-names>NE</given-names></name><name><surname>Rubben</surname><given-names>A</given-names></name><name><surname>Merk</surname><given-names>HF</given-names></name><name><surname>Pallua</surname><given-names>N</given-names></name></person-group><article-title>Radical resection of giant congenital melanocyte nevus and reconstruction with meek-graft covered integra dermal template</article-title><source>Dermatol Surg</source><year>2003</year><volume>29</volume><issue>6</issue><fpage>653</fpage><lpage>657</lpage><pub-id pub-id-type="pmid">12786713</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moiemen</surname><given-names>NS</given-names></name><name><surname>Vlachou</surname><given-names>E</given-names></name><name><surname>Staiano</surname><given-names>JJ</given-names></name><name><surname>Thawy</surname><given-names>Y</given-names></name><name><surname>Frame</surname><given-names>JD</given-names></name></person-group><article-title>Reconstructive surgery with Integra dermal regeneration template: histologic study, clinical evaluation, and current practice</article-title><source>Plast Reconstr Surg</source><year>2006</year><volume>117</volume><issue>7 Suppl</issue><fpage>160S</fpage><lpage>174S</lpage><pub-id pub-id-type="doi">10.1097/01.prs.0000222609.40461.68</pub-id><pub-id pub-id-type="pmid">16799385</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Herndon</surname><given-names>DN</given-names></name></person-group><source>Total burn care</source><year>2012</year><edition>4</edition><publisher-loc>Phildelphia</publisher-loc><publisher-name>W.B. Saunders</publisher-name></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kagan</surname><given-names>RJ</given-names></name><name><surname>Robb</surname><given-names>EC</given-names></name><name><surname>Plessinger</surname><given-names>RT</given-names></name></person-group><article-title>Human skin banking</article-title><source>Clin Lab Med</source><year>2005</year><volume>25</volume><issue>3</issue><fpage>587</fpage><lpage>605</lpage><pub-id pub-id-type="doi">10.1016/j.cll.2005.06.008</pub-id><pub-id pub-id-type="pmid">16129195</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harris</surname><given-names>RP</given-names></name><name><surname>Compton</surname><given-names>JB</given-names></name><name><surname>Abstan</surname><given-names>S</given-names></name></person-group><article-title>Comparison of fresh, frozen, and lyophilized porcine skin as xenografts on burned patients</article-title><source>Burns</source><year>1976</year><volume>2</volume><fpage>71</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1016/S0305-4179(76)80001-0</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burkey</surname><given-names>B</given-names></name><name><surname>Davis</surname><given-names>W</given-names><suffix>3rd</suffix></name><name><surname>Glat</surname><given-names>PM</given-names></name></person-group><article-title>Porcine xenograft treatment of superficial partial-thickness burns in paediatric patients</article-title><source>J Wound Care</source><year>2016</year><volume>25</volume><issue>2</issue><fpage>S10</fpage><lpage>S15</lpage><pub-id pub-id-type="doi">10.12968/jowc.2016.25.Sup2.S10</pub-id><pub-id pub-id-type="pmid">26878369</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hermans</surname><given-names>MH</given-names></name></person-group><article-title>Porcine xenografts vs. (cryopreserved) allografts in the management of partial thickness burns: is there a clinical difference?</article-title><source>Burns</source><year>2014</year><volume>40</volume><issue>3</issue><fpage>408</fpage><lpage>415</lpage><pub-id pub-id-type="doi">10.1016/j.burns.2013.08.020</pub-id><pub-id pub-id-type="pmid">24018214</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schurr</surname><given-names>MJ</given-names></name><name><surname>Foster</surname><given-names>KN</given-names></name><name><surname>Lokuta</surname><given-names>MA</given-names></name><name><surname>Rasmussen</surname><given-names>CA</given-names></name><name><surname>Thomas-Virnig</surname><given-names>CL</given-names></name><name><surname>Faucher</surname><given-names>LD</given-names></name><name><surname>Caruso</surname><given-names>DM</given-names></name><name><surname>len-Hoffmann</surname><given-names>BL</given-names></name></person-group><article-title>Clinical evaluation of NIKS-based bioengineered skin substitute tissue in complex skin defects: phase I/IIa clinical trial results</article-title><source>Adv Wound Care (New Rochelle)</source><year>2012</year><volume>1</volume><issue>2</issue><fpage>95</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1089/wound.2011.0343</pub-id><pub-id pub-id-type="pmid">24527287</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sood</surname><given-names>R</given-names></name><name><surname>Roggy</surname><given-names>D</given-names></name><name><surname>Zieger</surname><given-names>M</given-names></name><name><surname>Balledux</surname><given-names>J</given-names></name><name><surname>Chaudhari</surname><given-names>S</given-names></name><name><surname>Koumanis</surname><given-names>DJ</given-names></name><name><surname>Mir</surname><given-names>HS</given-names></name><name><surname>Cohen</surname><given-names>A</given-names></name><name><surname>Knipe</surname><given-names>C</given-names></name><name><surname>Gabehart</surname><given-names>K</given-names></name><etal/></person-group><article-title>Cultured epithelial autografts for coverage of large burn wounds in eighty-eight patients: the Indiana University experience</article-title><source>J Burn Care Res</source><year>2010</year><volume>31</volume><issue>4</issue><fpage>559</fpage><lpage>568</lpage><pub-id pub-id-type="doi">10.1097/BCR.0b013e3181e4ca29</pub-id><pub-id pub-id-type="pmid">20616650</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gravante</surname><given-names>G</given-names></name><name><surname>Di Fede</surname><given-names>MC</given-names></name><name><surname>Araco</surname><given-names>A</given-names></name><name><surname>Grimaldi</surname><given-names>M</given-names></name><name><surname>De</surname><given-names>AB</given-names></name><name><surname>Arpino</surname><given-names>A</given-names></name><name><surname>Cervelli</surname><given-names>V</given-names></name><name><surname>Montone</surname><given-names>A</given-names></name></person-group><article-title>A randomized trial comparing ReCell system of epidermal cells delivery versus classic skin grafts for the treatment of deep partial thickness burns</article-title><source>Burns</source><year>2007</year><volume>33</volume><issue>8</issue><fpage>966</fpage><lpage>972</lpage><pub-id pub-id-type="doi">10.1016/j.burns.2007.04.011</pub-id><pub-id pub-id-type="pmid">17904748</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duranceau</surname><given-names>L</given-names></name><name><surname>Genest</surname><given-names>H</given-names></name><name><surname>Bortoluzzi</surname><given-names>P</given-names></name><name><surname>Moulin</surname><given-names>V</given-names></name><name><surname>Auger</surname><given-names>FA</given-names></name><name><surname>Germain</surname><given-names>L</given-names></name></person-group><article-title>Successful grafting of a novel autologous tissue-engineered skin substitutes (dermis and epidermis) on twelve burn patients</article-title><source>J Burn Care Res</source><year>2014</year><volume>35</volume><issue>3</issue><fpage>S121</fpage></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyce</surname><given-names>ST</given-names></name><name><surname>Warden</surname><given-names>GD</given-names></name></person-group><article-title>Principles and practices for treatment of cutaneous wounds with cultured skin substitutes</article-title><source>Am J Surg</source><year>2002</year><volume>183</volume><issue>4</issue><fpage>445</fpage><lpage>456</lpage><pub-id pub-id-type="doi">10.1016/S0002-9610(02)00813-9</pub-id><pub-id pub-id-type="pmid">11975935</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hansbrough</surname><given-names>JF</given-names></name><name><surname>Boyce</surname><given-names>ST</given-names></name><name><surname>Cooper</surname><given-names>ML</given-names></name><name><surname>Foreman</surname><given-names>TJ</given-names></name></person-group><article-title>Burn wound closure with cultured autologous keratinocytes and fibroblasts attached to a collagen-glycosaminoglycan substrate</article-title><source>JAMA</source><year>1989</year><volume>262</volume><issue>15</issue><fpage>2125</fpage><lpage>2130</lpage><pub-id pub-id-type="doi">10.1001/jama.1989.03430150093032</pub-id><pub-id pub-id-type="pmid">2677425</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyce</surname><given-names>ST</given-names></name><name><surname>Simpson</surname><given-names>PS</given-names></name><name><surname>Rieman</surname><given-names>MT</given-names></name><name><surname>Warner</surname><given-names>PM</given-names></name><name><surname>Yakuboff</surname><given-names>KP</given-names></name><name><surname>Kevin</surname><given-names>BJ</given-names></name><name><surname>Nelson</surname><given-names>JK</given-names></name><name><surname>Fowler</surname><given-names>LA</given-names></name><name><surname>Kagan</surname><given-names>RJ</given-names></name></person-group><article-title>Randomized, paired-site comparison of autologous engineered skin substitutes and split-thickness skin graft for closure of extensive, full-thickness burns</article-title><source>J Burn Care Res</source><year>2017</year><volume>38</volume><issue>2</issue><fpage>61</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1097/BCR.0000000000000401</pub-id><pub-id pub-id-type="pmid">27404165</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Desai</surname><given-names>MH</given-names></name><name><surname>Mlakar</surname><given-names>JM</given-names></name><name><surname>McCauley</surname><given-names>RL</given-names></name><name><surname>Abdullah</surname><given-names>KM</given-names></name><name><surname>Rutan</surname><given-names>RL</given-names></name><name><surname>Waymack</surname><given-names>JP</given-names></name><name><surname>Robson</surname><given-names>MC</given-names></name><name><surname>Herndon</surname><given-names>DN</given-names></name></person-group><article-title>Lack of long term durability of cultured keratinocyte burn wound coverage: a case report</article-title><source>J Burn Care Rehabil</source><year>1991</year><volume>12</volume><fpage>540</fpage><lpage>545</lpage><pub-id pub-id-type="doi">10.1097/00004630-199111000-00009</pub-id><pub-id pub-id-type="pmid">1779008</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wood</surname><given-names>FM</given-names></name><name><surname>Kolybaba</surname><given-names>ML</given-names></name><name><surname>Allen</surname><given-names>P</given-names></name></person-group><article-title>The use of cultured epithelial autograft in the treatment of major burn injuries: a critical review of the literature</article-title><source>Burns</source><year>2006</year><volume>32</volume><issue>4</issue><fpage>395</fpage><lpage>401</lpage><pub-id pub-id-type="doi">10.1016/j.burns.2006.01.008</pub-id><pub-id pub-id-type="pmid">16621307</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sood</surname><given-names>R</given-names></name><name><surname>Roggy</surname><given-names>DE</given-names></name><name><surname>Zieger</surname><given-names>MJ</given-names></name><name><surname>Nazim</surname><given-names>M</given-names></name><name><surname>Hartman</surname><given-names>BC</given-names></name><name><surname>Gibbs</surname><given-names>JT</given-names></name></person-group><article-title>A comparative study of spray keratinocytes and autologous meshed split-thickness skin graft in the treatment of acute burn injuries</article-title><source>Wounds</source><year>2015</year><volume>27</volume><issue>2</issue><fpage>31</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">25785905</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyce</surname><given-names>ST</given-names></name><name><surname>Medrano</surname><given-names>EE</given-names></name><name><surname>Abdel-Malek</surname><given-names>ZA</given-names></name><name><surname>Supp</surname><given-names>AP</given-names></name><name><surname>Dodick</surname><given-names>JM</given-names></name><name><surname>Nordlund</surname><given-names>JJ</given-names></name><name><surname>Warden</surname><given-names>GD</given-names></name></person-group><article-title>Pigmentation and inhibition of wound contraction by cultured skin substitutes with adult melanocytes after transplantation to athymic mice</article-title><source>J Invest Dermat</source><year>1993</year><volume>100</volume><issue>4</issue><fpage>360</fpage><lpage>365</lpage><pub-id pub-id-type="doi">10.1111/1523-1747.ep12471822</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bottcher-Haberzeth</surname><given-names>S</given-names></name><name><surname>Klar</surname><given-names>AS</given-names></name><name><surname>Biedermann</surname><given-names>T</given-names></name><name><surname>Schiestl</surname><given-names>C</given-names></name><name><surname>Meuli-Simmen</surname><given-names>C</given-names></name><name><surname>Reichmann</surname><given-names>E</given-names></name><name><surname>Meuli</surname><given-names>M</given-names></name></person-group><article-title>&#x0201c;Trooping the color&#x0201d;: restoring the original donor skin color by addition of melanocytes to bioengineered skin analogs</article-title><source>Pediatr Surg Intl</source><year>2013</year><volume>29</volume><issue>3</issue><fpage>239</fpage><lpage>247</lpage><pub-id pub-id-type="doi">10.1007/s00383-012-3217-0</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duval</surname><given-names>C</given-names></name><name><surname>Chagnoleau</surname><given-names>C</given-names></name><name><surname>Pouradier</surname><given-names>F</given-names></name><name><surname>Sextius</surname><given-names>P</given-names></name><name><surname>Condom</surname><given-names>E</given-names></name><name><surname>Bernerd</surname><given-names>F</given-names></name></person-group><article-title>Human skin model containing melanocytes: essential role of keratinocyte growth factor for constitutive pigmentation-functional response to alpha-melanocyte stimulating hormone and forskolin</article-title><source>Tissue Eng Part C Methods</source><year>2012</year><volume>18</volume><issue>12</issue><fpage>947</fpage><lpage>957</lpage><pub-id pub-id-type="doi">10.1089/ten.tec.2011.0676</pub-id><pub-id pub-id-type="pmid">22646688</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Supp</surname><given-names>DM</given-names></name><name><surname>Wilson-Landy</surname><given-names>K</given-names></name><name><surname>Boyce</surname><given-names>ST</given-names></name></person-group><article-title>Human dermal microvascular endothelial cells form vascular analogs in cultured skin substitutes after grafting to athymic mice</article-title><source>FASEB J</source><year>2002</year><volume>16</volume><issue>8</issue><fpage>797</fpage><lpage>804</lpage><pub-id pub-id-type="doi">10.1096/fj.01-0868com</pub-id><pub-id pub-id-type="pmid">12039861</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Black</surname><given-names>AF</given-names></name><name><surname>Berthod</surname><given-names>F</given-names></name><name><surname>L'Heureux</surname><given-names>N</given-names></name><name><surname>Germain</surname><given-names>L</given-names></name><name><surname>Auger</surname><given-names>FA</given-names></name></person-group><article-title>In vitro reconstruction of a human capillary-like network in a tissue-engineered skin equivalent</article-title><source>FASEB J</source><year>1998</year><volume>12</volume><issue>13</issue><fpage>1331</fpage><lpage>1340</lpage><pub-id pub-id-type="doi">10.1096/fasebj.12.13.1331</pub-id><pub-id pub-id-type="pmid">9761776</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tremblay</surname><given-names>PL</given-names></name><name><surname>Hudon</surname><given-names>V</given-names></name><name><surname>Berthod</surname><given-names>F</given-names></name><name><surname>Germain</surname><given-names>L</given-names></name><name><surname>Auger</surname><given-names>FA</given-names></name></person-group><article-title>Inosculation of tissue-engineered capillaries with the host&#x02019;s vasculature in a reconstructed skin transplanted on mice</article-title><source>Am J Transplant</source><year>2005</year><volume>5</volume><issue>5</issue><fpage>1002</fpage><lpage>1010</lpage><pub-id pub-id-type="doi">10.1111/j.1600-6143.2005.00790.x</pub-id><pub-id pub-id-type="pmid">15816880</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhowmick</surname><given-names>S</given-names></name><name><surname>Scharnweber</surname><given-names>D</given-names></name><name><surname>Koul</surname><given-names>V</given-names></name></person-group><article-title>Co-cultivation of keratinocyte-human mesenchymal stem cell (hMSC) on sericin loaded electrospun nanofibrous composite scaffold (cationic gelatin/hyaluronan/chondroitin sulfate) stimulates epithelial differentiation in hMSCs: in vitro study</article-title><source>Biomaterials</source><year>2016</year><volume>88</volume><fpage>83</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.1016/j.biomaterials.2016.02.034</pub-id><pub-id pub-id-type="pmid">26946262</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klar</surname><given-names>AS</given-names></name><name><surname>Biedermann</surname><given-names>T</given-names></name><name><surname>Michalak</surname><given-names>K</given-names></name><name><surname>Michalczyk</surname><given-names>T</given-names></name><name><surname>Meuli-Simmen</surname><given-names>C</given-names></name><name><surname>Scherberich</surname><given-names>A</given-names></name><name><surname>Meuli</surname><given-names>M</given-names></name><name><surname>Reichmann</surname><given-names>E</given-names></name></person-group><article-title>Human adipose mesenchymal cells inhibit melanocyte differentiation and the pigmentation of human skin via increased expression of TGF-beta1</article-title><source>J Invest Dermatol</source><year>2017</year><volume>137</volume><issue>12</issue><fpage>2560</fpage><lpage>2569</lpage><pub-id pub-id-type="doi">10.1016/j.jid.2017.06.027</pub-id><pub-id pub-id-type="pmid">28774590</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>S</given-names></name><name><surname>Lu</surname><given-names>G</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Jirigala</surname><given-names>E</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Ma</surname><given-names>K</given-names></name><name><surname>Fu</surname><given-names>X</given-names></name></person-group><article-title>Mesenchymal stem cells delivered in a microsphere-based engineered skin contribute to cutaneous wound healing and sweat gland repair</article-title><source>J Dermatol Sci</source><year>2012</year><volume>66</volume><issue>1</issue><fpage>29</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1016/j.jdermsci.2012.02.002</pub-id><pub-id pub-id-type="pmid">22398148</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><mixed-citation publication-type="other">Morissette Martin P, Maux A, Laterreur V, Mayrand D, V LG, Moulin VJ, Fradette J. Enhancing repair of full-thickness excisional wounds in a murine model: impact of tissue-engineered biological dressings featuring human differentiated adipocytes. Acta Biomaterialia. 2015;22:39&#x02013;49.</mixed-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blais</surname><given-names>M</given-names></name><name><surname>Parenteau-Bareil</surname><given-names>R</given-names></name><name><surname>Cadau</surname><given-names>S</given-names></name><name><surname>Berthod</surname><given-names>F</given-names></name></person-group><article-title>Concise review: tissue-engineered skin and nerve regeneration in burn treatment</article-title><source>Stem Cells Transl Med</source><year>2013</year><volume>2</volume><issue>7</issue><fpage>545</fpage><lpage>551</lpage><pub-id pub-id-type="doi">10.5966/sctm.2012-0181</pub-id><pub-id pub-id-type="pmid">23734060</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sriwiriyanont</surname><given-names>P</given-names></name><name><surname>Lynch</surname><given-names>KA</given-names></name><name><surname>McFarland</surname><given-names>KL</given-names></name><name><surname>Supp</surname><given-names>DM</given-names></name><name><surname>Boyce</surname><given-names>ST</given-names></name></person-group><article-title>Characterization of hair follicle development in engineered skin substitutes</article-title><source>PLoS One</source><year>2013</year><volume>8</volume><issue>6</issue><fpage>e65664</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0065664</pub-id><pub-id pub-id-type="pmid">23799033</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gagnon</surname><given-names>V</given-names></name><name><surname>Larouche</surname><given-names>D</given-names></name><name><surname>Parenteau-Bareil</surname><given-names>R</given-names></name><name><surname>Gingras</surname><given-names>M</given-names></name><name><surname>Germain</surname><given-names>L</given-names></name><name><surname>Berthod</surname><given-names>F</given-names></name></person-group><article-title>Hair follicles guide nerve migration in vitro and in vivo in tissue-engineered skin</article-title><source>J Invest Dermatol</source><year>2011</year><volume>131</volume><issue>6</issue><fpage>1375</fpage><lpage>1378</lpage><pub-id pub-id-type="doi">10.1038/jid.2011.34</pub-id><pub-id pub-id-type="pmid">21368770</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agabalyan</surname><given-names>NA</given-names></name><name><surname>Rosin</surname><given-names>NL</given-names></name><name><surname>Rahmani</surname><given-names>W</given-names></name><name><surname>Biernaskie</surname><given-names>J</given-names></name></person-group><article-title>Hair follicle dermal stem cells and skin-derived precursor cells: exciting tools for endogenous and exogenous therapies</article-title><source>Exp Dermatol</source><year>2017</year><volume>26</volume><issue>6</issue><fpage>505</fpage><lpage>509</lpage><pub-id pub-id-type="doi">10.1111/exd.13359</pub-id><pub-id pub-id-type="pmid">28418596</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gledhill</surname><given-names>K</given-names></name><name><surname>Guo</surname><given-names>Z</given-names></name><name><surname>Umegaki-Arao</surname><given-names>N</given-names></name><name><surname>Higgins</surname><given-names>CA</given-names></name><name><surname>Itoh</surname><given-names>M</given-names></name><name><surname>Christiano</surname><given-names>AM</given-names></name></person-group><article-title>Melanin transfer in human 3D skin equivalents generated exclusively from induced pluripotent stem cells</article-title><source>PLoS One</source><year>2015</year><volume>10</volume><issue>8</issue><fpage>e0136713</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0136713</pub-id><pub-id pub-id-type="pmid">26308443</pub-id></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Itoh</surname><given-names>M</given-names></name><name><surname>Umegaki-Arao</surname><given-names>N</given-names></name><name><surname>Guo</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Higgins</surname><given-names>CA</given-names></name><name><surname>Christiano</surname><given-names>AM</given-names></name></person-group><article-title>Generation of 3D skin equivalents fully reconstituted from human induced pluripotent stem cells (iPSCs)</article-title><source>PLoS One</source><year>2013</year><volume>8</volume><issue>10</issue><fpage>e77673</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0077673</pub-id><pub-id pub-id-type="pmid">24147053</pub-id></element-citation></ref><ref id="CR59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyce</surname><given-names>ST</given-names></name><name><surname>Lloyd</surname><given-names>CM</given-names></name><name><surname>Kleiner</surname><given-names>MC</given-names></name><name><surname>Swope</surname><given-names>VB</given-names></name><name><surname>Abdel-Malek</surname><given-names>Z</given-names></name><name><surname>Supp</surname><given-names>DM</given-names></name></person-group><article-title>Restoration of cutaneous pigmentation by transplantation to mice of isogeneic human melanocytes in dermal-epidermal engineered skin substitutes</article-title><source>Pigment Cell Melanoma Res</source><year>2017</year><volume>30</volume><issue>6</issue><fpage>531</fpage><lpage>540</lpage><pub-id pub-id-type="doi">10.1111/pcmr.12609</pub-id><pub-id pub-id-type="pmid">28640957</pub-id></element-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Tomann</surname><given-names>P</given-names></name><name><surname>Andl</surname><given-names>T</given-names></name><name><surname>Gallant</surname><given-names>NM</given-names></name><name><surname>Huelsken</surname><given-names>J</given-names></name><name><surname>Jerchow</surname><given-names>B</given-names></name><name><surname>Birchmeier</surname><given-names>W</given-names></name><name><surname>Paus</surname><given-names>R</given-names></name><name><surname>Piccolo</surname><given-names>S</given-names></name><name><surname>Mikkola</surname><given-names>ML</given-names></name><etal/></person-group><article-title>Reciprocal requirements for EDA/EDAR/NF-kappaB and Wnt/beta-catenin signaling pathways in hair follicle induction</article-title><source>Dev Cell</source><year>2009</year><volume>17</volume><issue>1</issue><fpage>49</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2009.05.011</pub-id><pub-id pub-id-type="pmid">19619491</pub-id></element-citation></ref><ref id="CR61"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morgan</surname><given-names>BA</given-names></name></person-group><article-title>The dermal papilla: an instructive niche for epithelial stem and progenitor cells in development and regeneration of the hair follicle</article-title><source>Cold Spring Harb Perspect Med</source><year>2014</year><volume>4</volume><issue>7</issue><fpage>a015180</fpage><pub-id pub-id-type="doi">10.1101/cshperspect.a015180</pub-id><pub-id pub-id-type="pmid">24985131</pub-id></element-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morgan</surname><given-names>JR</given-names></name><name><surname>Barrandon</surname><given-names>Y</given-names></name><name><surname>Green</surname><given-names>H</given-names></name><name><surname>Mulligan</surname><given-names>RC</given-names></name></person-group><article-title>Expression of an exogenous growth hormone gene in transplantable human epidermal cells</article-title><source>Science</source><year>1987</year><volume>237</volume><fpage>1476</fpage><lpage>1479</lpage><pub-id pub-id-type="doi">10.1126/science.3629250</pub-id><pub-id pub-id-type="pmid">3629250</pub-id></element-citation></ref><ref id="CR63"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>JM</given-names></name><name><surname>Birinyi</surname><given-names>LK</given-names></name><name><surname>Salomon</surname><given-names>RN</given-names></name><name><surname>Libby</surname><given-names>P</given-names></name><name><surname>Callow</surname><given-names>AD</given-names></name><name><surname>Mulligan</surname><given-names>RC</given-names></name></person-group><article-title>Genetically modified endothelial cells in the treatment of human diseases</article-title><source>Trans Assoc Am Physicians</source><year>1989</year><volume>102</volume><fpage>139</fpage><lpage>147</lpage><pub-id pub-id-type="pmid">2638522</pub-id></element-citation></ref><ref id="CR64"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Selden</surname><given-names>RF</given-names></name><name><surname>Skoskiewicz</surname><given-names>MJ</given-names></name><name><surname>Howie</surname><given-names>KB</given-names></name><name><surname>Russell</surname><given-names>PS</given-names></name><name><surname>Goodman</surname><given-names>HM</given-names></name></person-group><article-title>Implantation of genetically engineered fibroblasts into mice: implications for gene therapy</article-title><source>Science</source><year>1987</year><volume>236</volume><issue>4802</issue><fpage>714</fpage><lpage>718</lpage><pub-id pub-id-type="doi">10.1126/science.3472348</pub-id><pub-id pub-id-type="pmid">3472348</pub-id></element-citation></ref><ref id="CR65"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clement</surname><given-names>F</given-names></name><name><surname>Grockowiak</surname><given-names>E</given-names></name><name><surname>Zylbersztejn</surname><given-names>F</given-names></name><name><surname>Fossard</surname><given-names>G</given-names></name><name><surname>Gobert</surname><given-names>S</given-names></name><name><surname>Maguer-Satta</surname><given-names>V</given-names></name></person-group><article-title>Stem cell manipulation, gene therapy and the risk of cancer stem cell emergence</article-title><source>Stem Cell Investig</source><year>2017</year><volume>4</volume><fpage>67</fpage><pub-id pub-id-type="doi">10.21037/sci.2017.07.03</pub-id><pub-id pub-id-type="pmid">28815178</pub-id></element-citation></ref><ref id="CR66"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>White</surname><given-names>M</given-names></name><name><surname>Whittaker</surname><given-names>R</given-names></name><name><surname>Gandara</surname><given-names>C</given-names></name><name><surname>Stoll</surname><given-names>EA</given-names></name></person-group><article-title>A guide to approaching regulatory considerations for lentiviral-mediated gene therapies</article-title><source>Hum Gene Ther Methods</source><year>2017</year><volume>28</volume><issue>4</issue><fpage>163</fpage><lpage>176</lpage><pub-id pub-id-type="doi">10.1089/hgtb.2017.096</pub-id><pub-id pub-id-type="pmid">28817344</pub-id></element-citation></ref><ref id="CR67"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bals</surname><given-names>R</given-names></name><name><surname>Weiner</surname><given-names>DJ</given-names></name><name><surname>Moscioni</surname><given-names>AD</given-names></name><name><surname>Meegalla</surname><given-names>RL</given-names></name><name><surname>Wilson</surname><given-names>JM</given-names></name></person-group><article-title>Augmentation of innate host defense by expression of a cathelicidin antimicrobial peptide</article-title><source>Infect Immun</source><year>1999</year><volume>67</volume><issue>11</issue><fpage>6084</fpage><lpage>6089</lpage><pub-id pub-id-type="pmid">10531270</pub-id></element-citation></ref><ref id="CR68"><label>68.</label><mixed-citation publication-type="other">Comer AR, Rasmussen CA, Thomas-Virnig CL, Lokuta MA, Shaughnessy LM, Schlosser SJ, Johnston CE, Bauer RL, Cleven TD, Wieczorek NC, et al. Preclinical development and planned clinical evaluation of a human skin substitute engineered to secrete elevated levels of a host defense peptide. Proceedings of the Innovations in Wound Healing Conference. 2014; (abstract).</mixed-citation></ref><ref id="CR69"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siprashvili</surname><given-names>Z</given-names></name><name><surname>Nguyen</surname><given-names>NT</given-names></name><name><surname>Bezchinsky</surname><given-names>MY</given-names></name><name><surname>Marinkovich</surname><given-names>MP</given-names></name><name><surname>Lane</surname><given-names>AT</given-names></name><name><surname>Khavari</surname><given-names>PA</given-names></name></person-group><article-title>Long-term type VII collagen restoration to human epidermolysis bullosa skin tissue</article-title><source>Hum Gene Ther</source><year>2010</year><volume>21</volume><issue>10</issue><fpage>1299</fpage><lpage>1310</lpage><pub-id pub-id-type="doi">10.1089/hum.2010.023</pub-id><pub-id pub-id-type="pmid">20497034</pub-id></element-citation></ref><ref id="CR70"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ortiz-Urda</surname><given-names>S</given-names></name><name><surname>Lin</surname><given-names>Q</given-names></name><name><surname>Green</surname><given-names>CL</given-names></name><name><surname>Keene</surname><given-names>DR</given-names></name><name><surname>Marinkovich</surname><given-names>MP</given-names></name><name><surname>Khavari</surname><given-names>PA</given-names></name></person-group><article-title>Injection of genetically engineered fibroblasts corrects regenerated human epidermolysis bullosa skin tissue</article-title><source>J Clin Invest</source><year>2003</year><volume>111</volume><issue>2</issue><fpage>251</fpage><lpage>255</lpage><pub-id pub-id-type="doi">10.1172/JCI200317193</pub-id><pub-id pub-id-type="pmid">12531881</pub-id></element-citation></ref><ref id="CR71"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gibson</surname><given-names>AL</given-names></name><name><surname>Thomas-Virnig</surname><given-names>CL</given-names></name><name><surname>Centanni</surname><given-names>JM</given-names></name><name><surname>Schlosser</surname><given-names>SJ</given-names></name><name><surname>Johnston</surname><given-names>CE</given-names></name><name><surname>Van Winkle</surname><given-names>KF</given-names></name><name><surname>Szilagyi</surname><given-names>A</given-names></name><name><surname>He</surname><given-names>LK</given-names></name><name><surname>Shankar</surname><given-names>R</given-names></name><name><surname>Allen-Hoffmann</surname><given-names>BL</given-names></name></person-group><article-title>Nonviral human beta defensin-3 expression in a bioengineered human skin tissue: a therapeutic alternative for infected wounds</article-title><source>Wound Repair Regen</source><year>2012</year><volume>20</volume><issue>3</issue><fpage>414</fpage><lpage>424</lpage><pub-id pub-id-type="doi">10.1111/j.1524-475X.2012.00786.x</pub-id><pub-id pub-id-type="pmid">22564233</pub-id></element-citation></ref><ref id="CR72"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Komor</surname><given-names>AC</given-names></name><name><surname>Badran</surname><given-names>AH</given-names></name><name><surname>Liu</surname><given-names>DR</given-names></name></person-group><article-title>CRISPR-based technologies for the manipulation of eukaryotic genomes</article-title><source>Cell</source><year>2017</year><volume>168</volume><issue>1-2</issue><fpage>20</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.10.044</pub-id><pub-id pub-id-type="pmid">27866654</pub-id></element-citation></ref><ref id="CR73"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Go</surname><given-names>DE</given-names></name><name><surname>Stottmann</surname><given-names>RW</given-names></name></person-group><article-title>The impact of CRISPR/Cas9-based genomic engineering on biomedical research and medicine</article-title><source>Curr Mol Med</source><year>2016</year><volume>16</volume><issue>4</issue><fpage>343</fpage><lpage>352</lpage><pub-id pub-id-type="doi">10.2174/1566524016666160316150847</pub-id><pub-id pub-id-type="pmid">26980700</pub-id></element-citation></ref><ref id="CR74"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>R</given-names></name><name><surname>Lin</surname><given-names>G</given-names></name><name><surname>Li</surname><given-names>J</given-names></name></person-group><article-title>Potential pitfalls of CRISPR/Cas9-mediated genome editing</article-title><source>FEBS J</source><year>2016</year><volume>283</volume><issue>7</issue><fpage>1218</fpage><lpage>1231</lpage><pub-id pub-id-type="doi">10.1111/febs.13586</pub-id><pub-id pub-id-type="pmid">26535798</pub-id></element-citation></ref><ref id="CR75"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patra</surname><given-names>S</given-names></name><name><surname>Young</surname><given-names>V</given-names></name></person-group><article-title>A review of 3D printing techniques and the future in biofabrication of bioprinted tissue</article-title><source>Cell Biochem Biophys</source><year>2016</year><volume>74</volume><issue>2</issue><fpage>93</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1007/s12013-016-0730-0</pub-id><pub-id pub-id-type="pmid">27193609</pub-id></element-citation></ref><ref id="CR76"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>V</given-names></name><name><surname>Singh</surname><given-names>G</given-names></name><name><surname>Trasatti</surname><given-names>JP</given-names></name><name><surname>Bjornsson</surname><given-names>C</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Tran</surname><given-names>TN</given-names></name><name><surname>Yoo</surname><given-names>SS</given-names></name><name><surname>Dai</surname><given-names>G</given-names></name><name><surname>Karande</surname><given-names>P</given-names></name></person-group><article-title>Design and fabrication of human skin by three-dimensional bioprinting</article-title><source>Tissue Engineering Part C Methods</source><year>2014</year><volume>20</volume><issue>6</issue><fpage>473</fpage><lpage>484</lpage><pub-id pub-id-type="doi">10.1089/ten.tec.2013.0335</pub-id><pub-id pub-id-type="pmid">24188635</pub-id></element-citation></ref><ref id="CR77"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cui</surname><given-names>X</given-names></name><name><surname>Boland</surname><given-names>T</given-names></name></person-group><article-title>Human microvasculature fabrication using thermal inkjet printing technology</article-title><source>Biomaterials</source><year>2009</year><volume>30</volume><issue>31</issue><fpage>6221</fpage><lpage>6227</lpage><pub-id pub-id-type="doi">10.1016/j.biomaterials.2009.07.056</pub-id><pub-id pub-id-type="pmid">19695697</pub-id></element-citation></ref><ref id="CR78"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koch</surname><given-names>L</given-names></name><name><surname>Deiwick</surname><given-names>A</given-names></name><name><surname>Schlie</surname><given-names>S</given-names></name><name><surname>Michael</surname><given-names>S</given-names></name><name><surname>Gruene</surname><given-names>M</given-names></name><name><surname>Coger</surname><given-names>V</given-names></name><name><surname>Zychlinski</surname><given-names>D</given-names></name><name><surname>Schambach</surname><given-names>A</given-names></name><name><surname>Reimers</surname><given-names>K</given-names></name><name><surname>Vogt</surname><given-names>PM</given-names></name><etal/></person-group><article-title>Skin tissue generation by laser cell printing</article-title><source>Biotechnol Bioeng</source><year>2012</year><volume>109</volume><issue>7</issue><fpage>1855</fpage><lpage>1863</lpage><pub-id pub-id-type="doi">10.1002/bit.24455</pub-id><pub-id pub-id-type="pmid">22328297</pub-id></element-citation></ref><ref id="CR79"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>HJ</given-names></name><name><surname>Youn</surname><given-names>SW</given-names></name><name><surname>Cheon</surname><given-names>SI</given-names></name><name><surname>Kim</surname><given-names>TY</given-names></name><name><surname>Hur</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>SY</given-names></name><name><surname>Lee</surname><given-names>SP</given-names></name><name><surname>Park</surname><given-names>KW</given-names></name><name><surname>Lee</surname><given-names>MM</given-names></name><name><surname>Choi</surname><given-names>YS</given-names></name><etal/></person-group><article-title>Regulation of endothelial cell and endothelial progenitor cell survival and vasculogenesis by integrin-linked kinase</article-title><source>Arterioscler Thromb Vasc Biol</source><year>2005</year><volume>25</volume><issue>6</issue><fpage>1154</fpage><lpage>1160</lpage><pub-id pub-id-type="doi">10.1161/01.ATV.0000164312.20008.93</pub-id><pub-id pub-id-type="pmid">15802621</pub-id></element-citation></ref><ref id="CR80"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burke-Smith</surname><given-names>A</given-names></name><name><surname>Collier</surname><given-names>J</given-names></name><name><surname>Jones</surname><given-names>I</given-names></name></person-group><article-title>A comparison of non-invasive imaging modalities: Infrared thermography, spectrophotometric intracutaneous analysis and laser Doppler imaging for the assessment of adult burns</article-title><source>Burns</source><year>2015</year><volume>41</volume><issue>8</issue><fpage>1695</fpage><lpage>1707</lpage><pub-id pub-id-type="doi">10.1016/j.burns.2015.06.023</pub-id><pub-id pub-id-type="pmid">26421694</pub-id></element-citation></ref><ref id="CR81"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaskille</surname><given-names>AD</given-names></name><name><surname>Ramella-Roman</surname><given-names>JC</given-names></name><name><surname>Shupp</surname><given-names>JW</given-names></name><name><surname>Jordan</surname><given-names>MH</given-names></name><name><surname>Jeng</surname><given-names>JC</given-names></name></person-group><article-title>Critical review of burn depth assessment techniques: part II. Review of laser doppler technology</article-title><source>J Burn Care Res</source><year>2010</year><volume>31</volume><issue>1</issue><fpage>151</fpage><lpage>157</lpage><pub-id pub-id-type="doi">10.1097/BCR.0b013e3181c7ed60</pub-id><pub-id pub-id-type="pmid">20061851</pub-id></element-citation></ref><ref id="CR82"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ida</surname><given-names>T</given-names></name><name><surname>Iwazaki</surname><given-names>H</given-names></name><name><surname>Kawaguchi</surname><given-names>Y</given-names></name><name><surname>Kawauchi</surname><given-names>S</given-names></name><name><surname>Ohkura</surname><given-names>T</given-names></name><name><surname>Iwaya</surname><given-names>K</given-names></name><name><surname>Tsuda</surname><given-names>H</given-names></name><name><surname>Saitoh</surname><given-names>D</given-names></name><name><surname>Sato</surname><given-names>S</given-names></name><name><surname>Iwai</surname><given-names>T</given-names></name></person-group><article-title>Burn depth assessments by photoacoustic imaging and laser Doppler imaging</article-title><source>Wound Repair Regen</source><year>2016</year><volume>24</volume><issue>2</issue><fpage>349</fpage><lpage>355</lpage><pub-id pub-id-type="doi">10.1111/wrr.12374</pub-id><pub-id pub-id-type="pmid">26487320</pub-id></element-citation></ref><ref id="CR83"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farrar</surname><given-names>E</given-names></name><name><surname>Pujji</surname><given-names>O</given-names></name><name><surname>Jeffery</surname><given-names>S</given-names></name></person-group><article-title>Three-dimensional wound mapping software compared to expert opinion in determining wound area</article-title><source>Burns</source><year>2017</year><volume>43</volume><issue>8</issue><fpage>1736</fpage><lpage>1741</lpage><pub-id pub-id-type="doi">10.1016/j.burns.2017.05.015</pub-id><pub-id pub-id-type="pmid">28801150</pub-id></element-citation></ref><ref id="CR84"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bailey</surname><given-names>JK</given-names></name><name><surname>Burkes</surname><given-names>SA</given-names></name><name><surname>Visscher</surname><given-names>MO</given-names></name><name><surname>Whitestone</surname><given-names>J</given-names></name><name><surname>Kagan</surname><given-names>RJ</given-names></name><name><surname>Yakuboff</surname><given-names>KP</given-names></name><name><surname>Warner</surname><given-names>P</given-names></name><name><surname>Randall Wickett</surname><given-names>R</given-names></name></person-group><article-title>Multimodal quantitative analysis of early pulsed-dye laser treatment of scars at a pediatric burn hospital</article-title><source>Dermatol Surg</source><year>2012</year><volume>38</volume><issue>9</issue><fpage>1490</fpage><lpage>1496</lpage><pub-id pub-id-type="doi">10.1111/j.1524-4725.2012.02451.x</pub-id><pub-id pub-id-type="pmid">22672578</pub-id></element-citation></ref><ref id="CR85"><label>85.</label><mixed-citation publication-type="other">Serup J, Jemed GBE, Grove GL. Handbook of non-invasive methods and the skin, 2nd edn. CRC Press, Inc.: Boca Raton; 2006.</mixed-citation></ref><ref id="CR86"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>US Food and Drug Administration</collab></person-group><article-title>Guidance for industry: guidance for human somatic cell therapy and gene therapy</article-title><source>Federal Register</source><year>1998</year><volume>63</volume><fpage>36413</fpage></element-citation></ref><ref id="CR87"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>US Food and Drug Administration</collab></person-group><article-title>Guidance for industry: chronic cutaneous ulcer and burn wounds - developing products for treatment</article-title><source>Federal Register</source><year>2006</year><volume>65</volume><issue>125</issue><fpage>39912</fpage></element-citation></ref><ref id="CR88"><label>88.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>American Society for Testing and Materials</collab></person-group><source>Standard guide for preservation of tissue engineered medical products. In., Report No.: F 2386-04</source><year>2007</year><publisher-loc>West Conshohocken</publisher-loc><publisher-name>ASTM International</publisher-name></element-citation></ref><ref id="CR89"><label>89.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>American Society for Testing and Materials</collab></person-group><source>Standard guide for classification of therapeutic skin substitutes. In., Report No.: F 2311-08</source><year>2009</year><publisher-loc>West Conshohocken</publisher-loc><publisher-name>ASTM International</publisher-name></element-citation></ref><ref id="CR90"><label>90.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>US Food and Drug Administration</collab></person-group><source>Guidance for industry: how to write a request for designation</source><year>2011</year></element-citation></ref><ref id="CR91"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Witten</surname><given-names>CM</given-names></name><name><surname>McFarland</surname><given-names>RD</given-names></name><name><surname>Simek</surname><given-names>SL</given-names></name></person-group><article-title>Concise review: the U.S. Food and Drug Administration and Regenerative Medicine</article-title><source>Stem Cells Transl Med</source><year>2015</year><volume>4</volume><issue>12</issue><fpage>1495</fpage><lpage>1499</lpage><pub-id pub-id-type="doi">10.5966/sctm.2015-0098</pub-id><pub-id pub-id-type="pmid">26494784</pub-id></element-citation></ref><ref id="CR92"><label>92.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>US Food and Drug Administration</collab></person-group><source>Expanded access for medical devices: compassionate use</source><year>2014</year></element-citation></ref><ref id="CR93"><label>93.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>US Food and Drug Administration</collab></person-group><source>Expanded access (Compassionate use)</source><year>2017</year></element-citation></ref><ref id="CR94"><label>94.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>US Food and Drug Administration</collab></person-group><source>21st century cures act</source><year>2017</year></element-citation></ref><ref id="CR95"><label>95.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>US Food and Drug Administration</collab></person-group><source>Fast track</source><year>2017</year></element-citation></ref><ref id="CR96"><label>96.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>US Food and Drug Administration</collab></person-group><source>Breakthrough therapy</source><year>2017</year></element-citation></ref><ref id="CR97"><label>97.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>US Food and Drug Administration</collab></person-group><source>Accelerated approval</source><year>2017</year></element-citation></ref><ref id="CR98"><label>98.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>US Food and Drug Administration</collab></person-group><source>Priority review</source><year>2017</year></element-citation></ref><ref id="CR99"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyce</surname><given-names>ST</given-names></name></person-group><article-title>Design principles for composition and performance of cultured skin substitutes</article-title><source>Burns</source><year>2001</year><volume>27</volume><issue>5</issue><fpage>523</fpage><lpage>533</lpage><pub-id pub-id-type="doi">10.1016/S0305-4179(01)00019-5</pub-id><pub-id pub-id-type="pmid">11451611</pub-id></element-citation></ref><ref id="CR100"><label>100.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Boyce</surname><given-names>ST</given-names></name><name><surname>Supp</surname><given-names>DM</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Albanna</surname><given-names>MZ</given-names></name><name><surname>Holmes</surname><given-names>JH</given-names></name></person-group><article-title>Biologic skin substitutes</article-title><source>Skin tissue engineering and regenerative medicine</source><year>2016</year><publisher-loc>New York</publisher-loc><publisher-name>Academic Press/Elsevier</publisher-name><fpage>211</fpage><lpage>238</lpage></element-citation></ref><ref id="CR101"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lohana</surname><given-names>P</given-names></name><name><surname>Hassan</surname><given-names>S</given-names></name><name><surname>Watson</surname><given-names>SB</given-names></name></person-group><article-title>Integra in burns reconstruction: our experience and report of an unusual immunological reaction</article-title><source>Ann Burns Fire Disasters</source><year>2014</year><volume>27</volume><issue>1</issue><fpage>17</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">25249843</pub-id></element-citation></ref><ref id="CR102"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ellis</surname><given-names>CV</given-names></name><name><surname>Kulber</surname><given-names>DA</given-names></name></person-group><article-title>Acellular dermal matrices in hand reconstruction</article-title><source>Plast Reconstr Surg</source><year>2012</year><volume>130</volume><issue>5 Suppl 2</issue><fpage>256S</fpage><lpage>269S</lpage><pub-id pub-id-type="doi">10.1097/PRS.0b013e318265a5cf</pub-id><pub-id pub-id-type="pmid">23096981</pub-id></element-citation></ref><ref id="CR103"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halim</surname><given-names>AS</given-names></name><name><surname>Khoo</surname><given-names>TL</given-names></name><name><surname>Mohd Yussof</surname><given-names>SJ</given-names></name></person-group><article-title>Biologic and synthetic skin substitutes: an overview</article-title><source>Indian J Plast Surg</source><year>2010</year><volume>43</volume><issue>Suppl</issue><fpage>S23</fpage><lpage>S28</lpage><pub-id pub-id-type="doi">10.4103/0970-0358.70712</pub-id><pub-id pub-id-type="pmid">21321652</pub-id></element-citation></ref><ref id="CR104"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeVries</surname><given-names>HJC</given-names></name><name><surname>Mekkes</surname><given-names>JR</given-names></name><name><surname>Middelkoop</surname><given-names>E</given-names></name><name><surname>Hinrichs</surname><given-names>WLJ</given-names></name><name><surname>Wildevuur</surname><given-names>CHR</given-names></name></person-group><article-title>Dermal substitutes for full-thickness wounds in one-stage grafting model</article-title><source>Wound Repair Regen</source><year>1993</year><volume>1</volume><fpage>244</fpage><lpage>252</lpage><pub-id pub-id-type="doi">10.1046/j.1524-475X.1993.10410.x</pub-id><pub-id pub-id-type="pmid">17166101</pub-id></element-citation></ref><ref id="CR105"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Myers</surname><given-names>SR</given-names></name><name><surname>Partha</surname><given-names>VN</given-names></name><name><surname>Soranzo</surname><given-names>C</given-names></name><name><surname>Price</surname><given-names>RD</given-names></name><name><surname>Navsaria</surname><given-names>HA</given-names></name></person-group><article-title>Hyalomatrix: a temporary epidermal barrier, hyaluronan delivery, and neodermis induction system for keratinocyte stem cell therapy</article-title><source>Tissue Eng</source><year>2007</year><volume>13</volume><issue>11</issue><fpage>2733</fpage><lpage>2741</lpage><pub-id pub-id-type="doi">10.1089/ten.2007.0109</pub-id><pub-id pub-id-type="pmid">17880270</pub-id></element-citation></ref><ref id="CR106"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greenwood</surname><given-names>JE</given-names></name><name><surname>Dearman</surname><given-names>BL</given-names></name></person-group><article-title>Comparison of a sealed, polymer foam biodegradable temporizing matrix against Integra(R) dermal regeneration template in a porcine wound model</article-title><source>J Burn Care Res</source><year>2012</year><volume>33</volume><issue>1</issue><fpage>163</fpage><lpage>173</lpage><pub-id pub-id-type="doi">10.1097/BCR.0b013e318233fac1</pub-id><pub-id pub-id-type="pmid">22002205</pub-id></element-citation></ref><ref id="CR107"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>May</surname><given-names>SR</given-names></name><name><surname>DeClement</surname><given-names>F</given-names></name></person-group><article-title>Skin banking. Part I. Procurement of transplantable cadaveric allograft skin for burn wound coverage</article-title><source>J Burn Care Rehabil</source><year>1981</year><volume>2</volume><fpage>7</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1097/00004630-198101000-00003</pub-id></element-citation></ref><ref id="CR108"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Griffiths</surname><given-names>CEM</given-names></name><name><surname>Nickoloff</surname><given-names>BJ</given-names></name></person-group><article-title>Keratinocyte intercellular adhesion molecule-1 (ICAM-1) expression precedes dermal T lymphocyte infiltration in allergic contact dermatitis (Rhus dermatitis)</article-title><source>Am J Pathol</source><year>1989</year><volume>135</volume><fpage>1045</fpage><lpage>1053</lpage><pub-id pub-id-type="pmid">2574536</pub-id></element-citation></ref><ref id="CR109"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carlson</surname><given-names>M</given-names></name><name><surname>Faria</surname><given-names>K</given-names></name><name><surname>Shamis</surname><given-names>Y</given-names></name><name><surname>Leman</surname><given-names>J</given-names></name><name><surname>Ronfard</surname><given-names>V</given-names></name><name><surname>Garlick</surname><given-names>J</given-names></name></person-group><article-title>Epidermal stem cells are preserved during commercial-scale manufacture of a bilayered, living cellular construct (Apligraf(R))</article-title><source>Tissue Eng Part A</source><year>2011</year><volume>17</volume><issue>3-4</issue><fpage>487</fpage><lpage>493</lpage><pub-id pub-id-type="doi">10.1089/ten.tea.2010.0268</pub-id><pub-id pub-id-type="pmid">20849380</pub-id></element-citation></ref><ref id="CR110"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schurr</surname><given-names>MJ</given-names></name><name><surname>Foster</surname><given-names>KN</given-names></name><name><surname>Centanni</surname><given-names>JM</given-names></name><name><surname>Comer</surname><given-names>AR</given-names></name><name><surname>Wicks</surname><given-names>A</given-names></name><name><surname>Gibson</surname><given-names>AL</given-names></name><name><surname>Thomas-Virnig</surname><given-names>CL</given-names></name><name><surname>Schlosser</surname><given-names>SJ</given-names></name><name><surname>Faucher</surname><given-names>LD</given-names></name><name><surname>Lokuta</surname><given-names>MA</given-names></name><etal/></person-group><article-title>Phase I/II clinical evaluation of StrataGraft: a consistent, pathogen-free human skin substitute</article-title><source>J Trauma</source><year>2009</year><volume>66</volume><issue>3</issue><fpage>866</fpage><lpage>873</lpage><pub-id pub-id-type="doi">10.1097/TA.0b013e31819849d6</pub-id><pub-id pub-id-type="pmid">19276766</pub-id></element-citation></ref><ref id="CR111"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frykberg</surname><given-names>RG</given-names></name><name><surname>Marston</surname><given-names>WA</given-names></name><name><surname>Cardinal</surname><given-names>M</given-names></name></person-group><article-title>The incidence of lower-extremity amputation and bone resection in diabetic foot ulcer patients treated with a human fibroblast-derived dermal substitute</article-title><source>Adv Skin Wound Care</source><year>2015</year><volume>28</volume><issue>1</issue><fpage>17</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1097/01.ASW.0000456630.12766.e9</pub-id><pub-id pub-id-type="pmid">25407083</pub-id></element-citation></ref><ref id="CR112"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harding</surname><given-names>K</given-names></name><name><surname>Sumner</surname><given-names>M</given-names></name><name><surname>Cardinal</surname><given-names>M</given-names></name></person-group><article-title>A prospective, multicentre, randomised controlled study of human fibroblast-derived dermal substitute (Dermagraft) in patients with venous leg ulcers</article-title><source>Intnl Wound J</source><year>2013</year><volume>10</volume><issue>2</issue><fpage>132</fpage><lpage>137</lpage><pub-id pub-id-type="doi">10.1111/iwj.12053</pub-id></element-citation></ref><ref id="CR113"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gallico Iii</surname><given-names>GG</given-names></name><name><surname>O'Connor</surname><given-names>NE</given-names></name><name><surname>Compton</surname><given-names>CC</given-names></name><name><surname>Kehinde</surname><given-names>O</given-names></name><name><surname>Green</surname><given-names>H</given-names></name></person-group><article-title>Permanent coverage of large burn wounds with autologous cultured human epithelium</article-title><source>N Engl J Med</source><year>1984</year><volume>311</volume><fpage>448</fpage><lpage>451</lpage><pub-id pub-id-type="doi">10.1056/NEJM198408163110706</pub-id><pub-id pub-id-type="pmid">6379456</pub-id></element-citation></ref><ref id="CR114"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campanella</surname><given-names>SD</given-names></name><name><surname>Rapley</surname><given-names>P</given-names></name><name><surname>Ramelet</surname><given-names>AS</given-names></name></person-group><article-title>A randomised controlled pilot study comparing Mepitel &#x000ae; and SurfaSoft &#x000ae; on paediatric donor sites treated with Recell &#x000ae;</article-title><source>Burns</source><year>2011</year><volume>37</volume><issue>8</issue><fpage>1334</fpage><lpage>1342</lpage><pub-id pub-id-type="doi">10.1016/j.burns.2011.04.019</pub-id><pub-id pub-id-type="pmid">21982622</pub-id></element-citation></ref><ref id="CR115"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boa</surname><given-names>O</given-names></name><name><surname>Cloutier</surname><given-names>CB</given-names></name><name><surname>Genest</surname><given-names>H</given-names></name><name><surname>Labbe</surname><given-names>R</given-names></name><name><surname>Rodrigue</surname><given-names>B</given-names></name><name><surname>Soucy</surname><given-names>J</given-names></name><name><surname>Roy</surname><given-names>M</given-names></name><name><surname>Arsenault</surname><given-names>F</given-names></name><name><surname>Ospina</surname><given-names>CE</given-names></name><name><surname>Dube</surname><given-names>N</given-names></name><etal/></person-group><article-title>Prospective study on the treatment of lower-extremity chronic venous and mixed ulcers using tissue-engineered skin substitute made by the self-assembly approach</article-title><source>Adv Skin Wound Care</source><year>2013</year><volume>26</volume><issue>9</issue><fpage>400</fpage><lpage>409</lpage><pub-id pub-id-type="doi">10.1097/01.ASW.0000433102.48268.2a</pub-id><pub-id pub-id-type="pmid">23958872</pub-id></element-citation></ref><ref id="CR116"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyce</surname><given-names>ST</given-names></name><name><surname>Kagan</surname><given-names>RJ</given-names></name><name><surname>Greenhalgh</surname><given-names>DG</given-names></name><name><surname>Warner</surname><given-names>P</given-names></name><name><surname>Yakuboff</surname><given-names>KP</given-names></name><name><surname>Palmieri</surname><given-names>T</given-names></name><name><surname>Warden</surname><given-names>GD</given-names></name></person-group><article-title>Cultured skin substitutes reduce requirements for harvesting of skin autograft for closure of excised, full-thickness burns</article-title><source>J Trauma</source><year>2006</year><volume>60</volume><issue>4</issue><fpage>821</fpage><lpage>829</lpage><pub-id pub-id-type="pmid">16612303</pub-id></element-citation></ref><ref id="CR117"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elsholz</surname><given-names>F</given-names></name><name><surname>Harteneck</surname><given-names>C</given-names></name><name><surname>Muller</surname><given-names>W</given-names></name><name><surname>Friedland</surname><given-names>K</given-names></name></person-group><article-title>Calcium--a central regulator of keratinocyte differentiation in health and disease</article-title><source>Eur J Dermatol</source><year>2014</year><volume>24</volume><issue>6</issue><fpage>650</fpage><lpage>661</lpage><pub-id pub-id-type="pmid">25514792</pub-id></element-citation></ref><ref id="CR118"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyce</surname><given-names>ST</given-names></name><name><surname>Ham</surname><given-names>RG</given-names></name></person-group><article-title>Calcium-regulated differentiation of normal human epidermal keratinocytes in chemically defined clonal culture and serum-free serial culture</article-title><source>J Invest Dermatol</source><year>1983</year><volume>81</volume><issue>1 Suppl</issue><fpage>33s</fpage><lpage>40s</lpage><pub-id pub-id-type="doi">10.1111/1523-1747.ep12540422</pub-id><pub-id pub-id-type="pmid">6345690</pub-id></element-citation></ref><ref id="CR119"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rice</surname><given-names>RH</given-names></name><name><surname>Durbin-Johnson</surname><given-names>BP</given-names></name><name><surname>Ishitsuka</surname><given-names>Y</given-names></name><name><surname>Salemi</surname><given-names>M</given-names></name><name><surname>Phinney</surname><given-names>BS</given-names></name><name><surname>Rocke</surname><given-names>DM</given-names></name><name><surname>Roop</surname><given-names>DR</given-names></name></person-group><article-title>Proteomic analysis of loricrin knockout mouse epidermis</article-title><source>J Proteome Res</source><year>2016</year><volume>15</volume><issue>8</issue><fpage>2560</fpage><lpage>2566</lpage><pub-id pub-id-type="doi">10.1021/acs.jproteome.6b00108</pub-id><pub-id pub-id-type="pmid">27418529</pub-id></element-citation></ref><ref id="CR120"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wikramanayake</surname><given-names>TC</given-names></name><name><surname>Stojadinovic</surname><given-names>O</given-names></name><name><surname>Tomic-Canic</surname><given-names>M</given-names></name></person-group><article-title>Epidermal Differentiation in Barrier Maintenance and Wound Healing</article-title><source>Adv Wound Care (New Rochelle)</source><year>2014</year><volume>3</volume><issue>3</issue><fpage>272</fpage><lpage>280</lpage><pub-id pub-id-type="doi">10.1089/wound.2013.0503</pub-id><pub-id pub-id-type="pmid">24669361</pub-id></element-citation></ref><ref id="CR121"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feingold</surname><given-names>KR</given-names></name><name><surname>Elias</surname><given-names>PM</given-names></name></person-group><article-title>Role of lipids in the formation and maintenance of the cutaneous permeability barrier</article-title><source>Biochim Biophys Acta</source><year>2014</year><volume>1841</volume><issue>3</issue><fpage>280</fpage><lpage>294</lpage><pub-id pub-id-type="doi">10.1016/j.bbalip.2013.11.007</pub-id><pub-id pub-id-type="pmid">24262790</pub-id></element-citation></ref><ref id="CR122"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ponec</surname><given-names>M</given-names></name><name><surname>Weerheim</surname><given-names>A</given-names></name><name><surname>Kempenaar</surname><given-names>J</given-names></name><name><surname>Mulder</surname><given-names>A</given-names></name><name><surname>Gooris</surname><given-names>GS</given-names></name><name><surname>Bouwstra</surname><given-names>J</given-names></name><name><surname>Mommaas</surname><given-names>AM</given-names></name></person-group><article-title>The formation of competent barrier lipids in reconstructed human epidermis requires the presence of vitamin C</article-title><source>J Invest Dermatol</source><year>1997</year><volume>109</volume><issue>3</issue><fpage>348</fpage><lpage>355</lpage><pub-id pub-id-type="doi">10.1111/1523-1747.ep12336024</pub-id><pub-id pub-id-type="pmid">9284103</pub-id></element-citation></ref><ref id="CR123"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haass</surname><given-names>NK</given-names></name><name><surname>Smalley</surname><given-names>KS</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Herlyn</surname><given-names>M</given-names></name></person-group><article-title>Adhesion, migration and communication in melanocytes and melanoma</article-title><source>Pigment Cell Res</source><year>2005</year><volume>18</volume><issue>3</issue><fpage>150</fpage><lpage>159</lpage><pub-id pub-id-type="doi">10.1111/j.1600-0749.2005.00235.x</pub-id><pub-id pub-id-type="pmid">15892711</pub-id></element-citation></ref><ref id="CR124"><label>124.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Kramer</surname><given-names>IJ</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Kramer</surname><given-names>IJ</given-names></name></person-group><article-title>Integrins, cell survival, and cell proliferation</article-title><source>Cell Signalling</source><year>2016</year><edition>3</edition><publisher-loc>New York</publisher-loc><publisher-name>Academic Press</publisher-name><fpage>681</fpage><lpage>693</lpage></element-citation></ref><ref id="CR125"><label>125.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kippenberger</surname><given-names>S</given-names></name><name><surname>Hofmann</surname><given-names>M</given-names></name><name><surname>Zoller</surname><given-names>N</given-names></name><name><surname>Thaci</surname><given-names>D</given-names></name><name><surname>Muller</surname><given-names>J</given-names></name><name><surname>Kaufmann</surname><given-names>R</given-names></name><name><surname>Bernd</surname><given-names>A</given-names></name></person-group><article-title>Ligation of beta4 integrins activates PKB/Akt and ERK1/2 by distinct pathways-relevance of the keratin filament</article-title><source>Biochim Biophys Acta</source><year>2010</year><volume>1803</volume><issue>8</issue><fpage>940</fpage><lpage>950</lpage><pub-id pub-id-type="doi">10.1016/j.bbamcr.2010.03.009</pub-id><pub-id pub-id-type="pmid">20307589</pub-id></element-citation></ref><ref id="CR126"><label>126.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohyama</surname><given-names>M</given-names></name><name><surname>Zheng</surname><given-names>Y</given-names></name><name><surname>Paus</surname><given-names>R</given-names></name><name><surname>Stenn</surname><given-names>KS</given-names></name></person-group><article-title>The mesenchymal component of hair follicle neogenesis: background, methods and molecular characterization</article-title><source>Exp Dermatol</source><year>2009</year><volume>19</volume><issue>2</issue><fpage>89</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.1111/j.1600-0625.2009.00935.x</pub-id><pub-id pub-id-type="pmid">19650868</pub-id></element-citation></ref><ref id="CR127"><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chueh</surname><given-names>SC</given-names></name><name><surname>Lin</surname><given-names>SJ</given-names></name><name><surname>Chen</surname><given-names>CC</given-names></name><name><surname>Lei</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>LM</given-names></name><name><surname>Widelitz</surname><given-names>R</given-names></name><name><surname>Hughes</surname><given-names>MW</given-names></name><name><surname>Jiang</surname><given-names>TX</given-names></name><name><surname>Chuong</surname><given-names>CM</given-names></name></person-group><article-title>Therapeutic strategy for hair regeneration: hair cycle activation, niche environment modulation, wound-induced follicle neogenesis, and stem cell engineering</article-title><source>Expert Opin Biol Ther</source><year>2013</year><volume>13</volume><issue>3</issue><fpage>377</fpage><lpage>391</lpage><pub-id pub-id-type="doi">10.1517/14712598.2013.739601</pub-id><pub-id pub-id-type="pmid">23289545</pub-id></element-citation></ref><ref id="CR128"><label>128.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kiso</surname><given-names>M</given-names></name><name><surname>Tanaka</surname><given-names>S</given-names></name><name><surname>Saba</surname><given-names>R</given-names></name><name><surname>Matsuda</surname><given-names>S</given-names></name><name><surname>Shimizu</surname><given-names>A</given-names></name><name><surname>Ohyama</surname><given-names>M</given-names></name><name><surname>Okano</surname><given-names>HJ</given-names></name><name><surname>Shiroishi</surname><given-names>T</given-names></name><name><surname>Okano</surname><given-names>H</given-names></name><name><surname>Saga</surname><given-names>Y</given-names></name></person-group><article-title>The disruption of Sox21-mediated hair shaft cuticle differentiation causes cyclic alopecia in mice</article-title><source>Proc Natl Acad Sci USA</source><year>2009</year><volume>106</volume><issue>23</issue><fpage>9292</fpage><lpage>9297</lpage><pub-id pub-id-type="doi">10.1073/pnas.0808324106</pub-id><pub-id pub-id-type="pmid">19470461</pub-id></element-citation></ref><ref id="CR129"><label>129.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Driskell</surname><given-names>RR</given-names></name><name><surname>Clavel</surname><given-names>C</given-names></name><name><surname>Rendl</surname><given-names>M</given-names></name><name><surname>Watt</surname><given-names>FM</given-names></name></person-group><article-title>Hair follicle dermal papilla cells at a glance</article-title><source>J Cell Sci</source><year>2011</year><volume>124</volume><issue>Pt 8</issue><fpage>1179</fpage><lpage>1182</lpage><pub-id pub-id-type="doi">10.1242/jcs.082446</pub-id><pub-id pub-id-type="pmid">21444748</pub-id></element-citation></ref><ref id="CR130"><label>130.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>M</given-names></name><name><surname>Horrell</surname><given-names>J</given-names></name><name><surname>Snitow</surname><given-names>M</given-names></name><name><surname>Cui</surname><given-names>J</given-names></name><name><surname>Gochnauer</surname><given-names>H</given-names></name><name><surname>Syrett</surname><given-names>CM</given-names></name><name><surname>Kallish</surname><given-names>S</given-names></name><name><surname>Seykora</surname><given-names>JT</given-names></name><name><surname>Liu</surname><given-names>F</given-names></name><name><surname>Gaillard</surname><given-names>D</given-names></name><etal/></person-group><article-title>WNT10A mutation causes ectodermal dysplasia by impairing progenitor cell proliferation and KLF4-mediated differentiation</article-title><source>Nat Commun</source><year>2017</year><volume>8</volume><fpage>15397</fpage><pub-id pub-id-type="doi">10.1038/ncomms15397</pub-id><pub-id pub-id-type="pmid">28589954</pub-id></element-citation></ref><ref id="CR131"><label>131.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niemann</surname><given-names>C</given-names></name><name><surname>Horsley</surname><given-names>V</given-names></name></person-group><article-title>Development and homeostasis of the sebaceous gland</article-title><source>Semin Cell Dev Biol</source><year>2012</year><volume>23</volume><issue>8</issue><fpage>928</fpage><lpage>936</lpage><pub-id pub-id-type="doi">10.1016/j.semcdb.2012.08.010</pub-id><pub-id pub-id-type="pmid">22960253</pub-id></element-citation></ref><ref id="CR132"><label>132.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McNairn</surname><given-names>AJ</given-names></name><name><surname>Doucet</surname><given-names>Y</given-names></name><name><surname>Demaude</surname><given-names>J</given-names></name><name><surname>Brusadelli</surname><given-names>M</given-names></name><name><surname>Gordon</surname><given-names>CB</given-names></name><name><surname>Uribe-Rivera</surname><given-names>A</given-names></name><name><surname>Lambert</surname><given-names>PF</given-names></name><name><surname>Bouez</surname><given-names>C</given-names></name><name><surname>Breton</surname><given-names>L</given-names></name><name><surname>Guasch</surname><given-names>G</given-names></name></person-group><article-title>TGFbeta signaling regulates lipogenesis in human sebaceous glands cells</article-title><source>BMC Dermatol</source><year>2013</year><volume>13</volume><fpage>2</fpage><pub-id pub-id-type="doi">10.1186/1471-5945-13-2</pub-id><pub-id pub-id-type="pmid">23343495</pub-id></element-citation></ref><ref id="CR133"><label>133.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>C</given-names></name><name><surname>Fuchs</surname><given-names>E</given-names></name></person-group><article-title>Sweat gland progenitors in development, homeostasis, and wound repair</article-title><source>Cold Spring Harb Perspect Med</source><year>2014</year><volume>4</volume><issue>2</issue><fpage>a015222</fpage><pub-id pub-id-type="doi">10.1101/cshperspect.a015222</pub-id><pub-id pub-id-type="pmid">24492848</pub-id></element-citation></ref><ref id="CR134"><label>134.</label><mixed-citation publication-type="other">Zeng B, Xiao X, Li S, Lu H, Lu J, Zhu L, Yu D, Zhao W: Eight mutations of three genes (EDA, EDAR, and WNT10A) identified in seven hypohidrotic ectodermal dysplasia patients. Genes. 2016 7(9); epub. doi: 10.3390/genes7090065. PMID: 27657131.</mixed-citation></ref><ref id="CR135"><label>135.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cui</surname><given-names>CY</given-names></name><name><surname>Kunisada</surname><given-names>M</given-names></name><name><surname>Esibizione</surname><given-names>D</given-names></name><name><surname>Douglass</surname><given-names>EG</given-names></name><name><surname>Schlessinger</surname><given-names>D</given-names></name></person-group><article-title>Analysis of the temporal requirement for eda in hair and sweat gland development</article-title><source>J Invest Dermatol</source><year>2009</year><volume>129</volume><issue>4</issue><fpage>984</fpage><lpage>993</lpage><pub-id pub-id-type="doi">10.1038/jid.2008.318</pub-id><pub-id pub-id-type="pmid">18923450</pub-id></element-citation></ref><ref id="CR136"><label>136.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adameyko</surname><given-names>I</given-names></name><name><surname>Lallemend</surname><given-names>F</given-names></name><name><surname>Aquino</surname><given-names>JB</given-names></name><name><surname>Pereira</surname><given-names>JA</given-names></name><name><surname>Topilko</surname><given-names>P</given-names></name><name><surname>Muller</surname><given-names>T</given-names></name><name><surname>Fritz</surname><given-names>N</given-names></name><name><surname>Beljajeva</surname><given-names>A</given-names></name><name><surname>Mochii</surname><given-names>M</given-names></name><name><surname>Liste</surname><given-names>I</given-names></name><etal/></person-group><article-title>Schwann cell precursors from nerve innervation are a cellular origin of melanocytes in skin</article-title><source>Cell</source><year>2009</year><volume>139</volume><issue>2</issue><fpage>366</fpage><lpage>379</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2009.07.049</pub-id><pub-id pub-id-type="pmid">19837037</pub-id></element-citation></ref><ref id="CR137"><label>137.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cichorek</surname><given-names>M</given-names></name><name><surname>Wachulska</surname><given-names>M</given-names></name><name><surname>Stasiewicz</surname><given-names>A</given-names></name><name><surname>Tyminska</surname><given-names>A</given-names></name></person-group><article-title>Skin melanocytes: biology and development</article-title><source>Postepy Dermatol Alergol</source><year>2013</year><volume>30</volume><issue>1</issue><fpage>30</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.5114/pdia.2013.33376</pub-id><pub-id pub-id-type="pmid">24278043</pub-id></element-citation></ref><ref id="CR138"><label>138.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aoki</surname><given-names>Y</given-names></name><name><surname>Saint-Germain</surname><given-names>N</given-names></name><name><surname>Gyda</surname><given-names>M</given-names></name><name><surname>Magner-Fink</surname><given-names>E</given-names></name><name><surname>Lee</surname><given-names>YH</given-names></name><name><surname>Credidio</surname><given-names>C</given-names></name><name><surname>Saint-Jeannet</surname><given-names>JP</given-names></name></person-group><article-title>Sox10 regulates the development of neural crest-derived melanocytes in Xenopus</article-title><source>Dev Biol</source><year>2003</year><volume>259</volume><issue>1</issue><fpage>19</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1016/S0012-1606(03)00161-1</pub-id><pub-id pub-id-type="pmid">12812785</pub-id></element-citation></ref><ref id="CR139"><label>139.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaucka</surname><given-names>M</given-names></name><name><surname>Adameyko</surname><given-names>I</given-names></name></person-group><article-title>Non-canonical functions of the peripheral nerve</article-title><source>Exp Cell Res</source><year>2014</year><volume>321</volume><issue>1</issue><fpage>17</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1016/j.yexcr.2013.10.004</pub-id><pub-id pub-id-type="pmid">24140263</pub-id></element-citation></ref><ref id="CR140"><label>140.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biedermann</surname><given-names>T</given-names></name><name><surname>Klar</surname><given-names>AS</given-names></name><name><surname>Bottcher-Haberzeth</surname><given-names>S</given-names></name><name><surname>Schiestl</surname><given-names>C</given-names></name><name><surname>Reichmann</surname><given-names>E</given-names></name><name><surname>Meuli</surname><given-names>M</given-names></name></person-group><article-title>Tissue-engineered dermo-epidermal skin analogs exhibit de novo formation of a near natural neurovascular link 10 weeks after transplantation</article-title><source>Pediatr Surg Int</source><year>2014</year><volume>30</volume><issue>2</issue><fpage>165</fpage><lpage>172</lpage><pub-id pub-id-type="doi">10.1007/s00383-013-3446-x</pub-id><pub-id pub-id-type="pmid">24363058</pub-id></element-citation></ref><ref id="CR141"><label>141.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Francois</surname><given-names>M</given-names></name><name><surname>Koopman</surname><given-names>P</given-names></name><name><surname>Beltrame</surname><given-names>M</given-names></name></person-group><article-title>SoxF genes: key players in the development of the cardio-vascular system</article-title><source>Int J Biochem Cell Biol</source><year>2010</year><volume>42</volume><issue>3</issue><fpage>445</fpage><lpage>448</lpage><pub-id pub-id-type="doi">10.1016/j.biocel.2009.08.017</pub-id><pub-id pub-id-type="pmid">19733255</pub-id></element-citation></ref><ref id="CR142"><label>142.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wat</surname><given-names>JJ</given-names></name><name><surname>Wat</surname><given-names>MJ</given-names></name></person-group><article-title>Sox7 in vascular development: review, insights and potential mechanisms</article-title><source>Int J Dev Biol</source><year>2014</year><volume>58</volume><issue>1</issue><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1387/ijdb.130323mw</pub-id><pub-id pub-id-type="pmid">24860989</pub-id></element-citation></ref><ref id="CR143"><label>143.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruderer</surname><given-names>M</given-names></name><name><surname>Alini</surname><given-names>M</given-names></name><name><surname>Stoddart</surname><given-names>MJ</given-names></name></person-group><article-title>Role of HOXA9 and VEZF1 in endothelial biology</article-title><source>J Vasc Res</source><year>2013</year><volume>50</volume><issue>4</issue><fpage>265</fpage><lpage>278</lpage><pub-id pub-id-type="doi">10.1159/000353287</pub-id><pub-id pub-id-type="pmid">23921720</pub-id></element-citation></ref><ref id="CR144"><label>144.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janani</surname><given-names>C</given-names></name><name><surname>Ranjitha Kumari</surname><given-names>BD</given-names></name></person-group><article-title>PPAR gamma gene - A review</article-title><source>Diabetes Metab Syndr</source><year>2015</year><volume>9</volume><issue>1</issue><fpage>46</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1016/j.dsx.2014.09.015</pub-id><pub-id pub-id-type="pmid">25450819</pub-id></element-citation></ref><ref id="CR145"><label>145.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>S</given-names></name><name><surname>Kong</surname><given-names>X</given-names></name><name><surname>Rosen</surname><given-names>ED</given-names></name></person-group><article-title>Adipocyte-specific transgenic and knockout models</article-title><source>Methods Enzymol</source><year>2014</year><volume>537</volume><fpage>1</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1016/B978-0-12-411619-1.00001-X</pub-id><pub-id pub-id-type="pmid">24480338</pub-id></element-citation></ref><ref id="CR146"><label>146.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harms</surname><given-names>M</given-names></name><name><surname>Seale</surname><given-names>P</given-names></name></person-group><article-title>Brown and beige fat: development, function and therapeutic potential</article-title><source>Nat Med</source><year>2013</year><volume>19</volume><issue>10</issue><fpage>1252</fpage><lpage>1263</lpage><pub-id pub-id-type="doi">10.1038/nm.3361</pub-id><pub-id pub-id-type="pmid">24100998</pub-id></element-citation></ref></ref-list></back></article>